0001213900-24-015210.txt : 20240220 0001213900-24-015210.hdr.sgml : 20240220 20240220133506 ACCESSION NUMBER: 0001213900-24-015210 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genufood Energy Enzymes Corp. CENTRAL INDEX KEY: 0001510518 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 680681158 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-56112 FILM NUMBER: 24652174 BUSINESS ADDRESS: STREET 1: 1108 S. BALWAIN AVENUE, SUITE 107 CITY: ARCADIA STATE: CA ZIP: 91007 BUSINESS PHONE: (855) 707-2077 MAIL ADDRESS: STREET 1: 1108 S. BALWAIN AVENUE, SUITE 107 CITY: ARCADIA STATE: CA ZIP: 91007 10-Q 1 f10q1223_genufood.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2023

 

Commission File Number 000-56112

 

GENUFOOD ENERGY ENZYMES CORP.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other jurisdiction of incorporation or organization)

 

1108 S. Baldwin Avenue, Suite 107

Arcadia, California 91007

(Address of principal executive offices, including zip code.)

 

(855) 707-2077

(Telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
N/A    N/A    N/A 

 

Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO

 

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 808,900,041 shares as of February 15, 2024

 

 

 

 

 

 

GENUFOOD ENERGY ENZYMES CORP.

 

FORM 10-Q FOR THE THREE-MONTH PERIOD ENDED DECEMBER 31, 2023

 

TABLE OF CONTENTS

 

        Page
Number
    PART I. FINANCIAL INFORMATION    
         
ITEM 1.   CONDENSED CONSOLIDATED FINANCIAL STATEMENTS   1
ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   11
ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   14
ITEM 4.   CONTROLS AND PROCEDURES   15
         
    PART II. OTHER INFORMATION   17
         
ITEM 1.   LEGAL PROCEEDINGS   17
ITEM 1A.   RISK FACTORS   17
ITEM 2.   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS   17
ITEM 3.   DEFAULTS UPON SENIOR SECURITIES   17
ITEM 4.   MINE SAFETY DISCLOSURES   17
ITEM 5.   OTHER INFORMATION   17
ITEM 6.   EXHIBITS   18

 

i

 

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

GENUFOOD ENERGY ENZYMES CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   December 31,   September 30, 
   2023   2023 
   (Unaudited)     
Assets        
Current assets        
Cash and cash equivalents  $19,617   $125,924 
Prepayment   8,000    8,187 
Total Current Assets   27,617    134,111 
           
Equipment   96,142    67,451 
           
Total Assets  $123,759   $201,562 
           
Liabilities and Stockholders’ (Deficit) Equity          
Current liabilities          
Accounts payable  $111,849   $100,849 
Accrued expenses   37    37 
Due to related parties   4,437    14,730 
Total Current Liabilities   116,323    115,616 
           
Commitment and contingencies (Note 8)   32,976    32,226 
           
Stockholders’ (Deficit) Equity          
Common stock: $0.001 par value; 10,000,000,000 shares authorized; 808,900,041 shares issued and outstanding as of December 31, 2023 and September 30, 2023   808,900    808,900 
Additional paid-in capital   17,008,342    16,989,592 
Discount on common stock   (7,241,581)   (7,241,581)
Accumulated deficit   (10,601,201)   (10,503,191)
Total Stockholders’ (Deficit) Equity   (25,540)   53,720 
           
Total Liabilities and Stockholders’ (Deficit) Equity  $123,759   $201,562 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

1

 

 

GENUFOOD ENERGY ENZYMES CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

   For the Three Months Ended
December 31,
 
   2023   2022 
       (Restated) 
Revenue  $
-
   $
-
 
           
Operating expenses          
General and administrative expenses   95,616    148,995 
Total operating expenses   95,616    148,995 
           
Loss from operations   (95,616)   (148,995)
           
Other income (expense)          
Interest expense   (44)   
-
 
Foreign currency loss   
-
    (43)
Other non-operating income (expenses), net   (750)   (750)
Total other (expense) income   (794)   (793)
           
Loss before income taxes   (96,410)   (149,788)
           
Provision for income taxes   1,600    
-
 
           
Net loss   (98,010)   (149,788)
           
Other comprehensive income (loss)          
Foreign currency transaction adjustment   
-
    (85)
           
Comprehensive loss  $(98,010)  $(149,873)
           
Loss per share of common stock - basic and diluted   *    * 
           
Weighted average shares outstanding - basic and diluted
   808,900,041    299,686,921 

 

*Less than $0.01 per share

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2

 

 

GENUFOOD ENERGY ENZYMES CORPORATION

CONDENSED CONSOILDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

 

                   Accumulated     
   Common Stock   Additional   Discount on       Other   Total 
   Number of      Paid-in-   common   Accumulated   Comprehensive   Stockholder’s 
   Shares   Amount   Capital   stock   Deficit   Income (loss)   Equity 
Balance at September 30, 2023 

808,900,041

   $808,900   $16,989,592   $(7,241,581)  $(10,503,191)  $              -   $53,720 
Stock-based compensation   -    -    18,750    -    -    -    18,750 
Net Loss   -    -    -    -    (98,010)   -    (98,010)
Balance at December 31, 2023   

808,900,041

   $808,900   $17,008,342   $(7,241,581)  $(10,601,201)  $-   $(25,540)

 

                       Accumulated     
   Common Stock   Additional   Discount on       Other   Total 
   Number of       Paid-in-   common   Accumulated   Comprehensive   Stockholder’s 
   Shares   Amount   Capital   stock   Deficit   Income (loss)   Equity 
Balance at September 30, 2022 (restated)   

299,686,921

   $299,687   $16,927,592   $(7,241,581)  $(9,875,489)  $(193,558)  $(83,349)
Stock-based compensation (restated)   -    -    18,750    -    -    -    18,750 
Foreign currency translation   -    -    -    -    -    (85)   (85)
Net loss (restated)   -    -    -    -    (149,788)   -    (149,788)
Balance at December 31, 2022 (restated)   

299,686,921

   $299,687   $16,946,342   $(7,241,581)  $(10,025,277)  $(193,643)  $(214,472)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

 

GENUFOOD ENERGY ENZYMES CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   For the Three Months Ended 
   December 31, 
   2023   2022 
       (Restated) 
Cash Flows from Operating Activities          
Net loss  $(98,010)  $(149,788)
Adjustments to reconcile net loss to net cash used in operating activities          
Stock-based compensation   18,750    18,750 
Change in operating assets and liabilities          
Prepayment   187    7,836 
Accounts payable   11,000    17,401 
Due to related parties   (10,293)   30,182 
Commitment and contingencies   750    750 
Net cash used in operating activities   (77,616)   (74,869)
           
Cash Flows from Investing Activities          
Purchase of equipment   (28,691)   (15,005)
Net cash used in investing activities   (28,691)   (15,005)
           
Net decrease in cash and cash equivalents   (106,307)   (89,874)
           
Cash and cash equivalents, beginning of period   125,924    136,400 
           
Cash and cash equivalents, end of period  $19,617   $46,526 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for interest  $
-
   $
-
 
Cash paid for income taxes  $1,600   $
-
 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

GENUFOOD ENERGY ENZYMES CORP

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

NOTE 1 – GENERAL ORGANIZATION AND BUSINESS

 

Genufood Energy Enzymes Corp., USA (the “Company” or “GEEC”) was incorporated under the laws of the State of Nevada on June 21, 2010. On February 13, 2012, GEEC incorporated a wholly-owned subsidiary, Genufood Enzymes (S) Pte Ltd (“GESPL”) in Singapore, which was dissolved on January 9, 2023.

 

Since its inception, the Company has always been in the development stage and never generated significant revenues. The Company is currently developing business in Electric Vehicle Charge station. The Company has engaged in business agreements and development with various parties. The Company has initiated its electric vehicle charging station business.

 

On August 1, 2022, the board of directors (the “Board”) of the Company unanimously approved to expand our business in the area of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such industry. On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless technology and carbon-neutral vehicle-charging infrastructure.

 

On October 26, 2022, the Company entered into three Charging Station Site Host Agreements (the “Agreements”) with two institutions (the “Site Hosts”), respectively, pursuant to which the Site Hosts agree to allow the Company to install its electric vehicle charging stations at the locations set forth in the Agreements (the “Charging Stations”). Under the Agreements, the Company has agreed to share the revenue generated by the sales of electricity at the Charging Stations with the Site Hosts.

 

As of December 31, 2023, the Company has two sites under construction for charging stations and three sites under planning.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company’s condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending September 30, 2024. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023.

 

Principle of Consolidation

 

The condensed consolidated financial statements include the accounts of GEEC and its wholly-owned subsidiary GESPL. All significant inter-company accounts and transactions have been eliminated in consolidation. The wholly-owned subsidiary of the Company did not have business activities prior to its dissolution.

 

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

5

 

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, to the extent balances exceeded limits that were insured by the Federal Deposit Insurance Corporation. The Company does not require collateral and maintains reserves for potential credit losses. Such losses have historically been immaterial and have been within management’s expectations.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with original maturities of three months or less when acquired to be cash equivalents. As of December 31, 2023 and September 30, 2023, the Company did not have cash equivalents.

 

Fair Value of Financial Instruments

 

The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 inputs are quoted prices available for identical assets and liabilities in active markets.
     
  Level 2 inputs are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets or other inputs that are observable or can be corroborated by observable market data.
     
  Level 3 inputs are less observable and reflect our own assumptions.

 

The Company’s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued expenses and due to related parties. The carrying amounts of such financial instruments in the accompanying consolidated balance sheets approximate their fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.

 

Foreign Currency Translation and Transactions

 

The reporting and functional currency of GEEC is the USD. The functional currency of GESPL, a wholly owned subsidiary of GEEC, is the Singapore Dollar (“SGD”).

 

For financial reporting purposes, the financial statements of the Company’s Singapore subsidiary, which are prepared using the SGD, are translated into the Company’s reporting currency, USD. Assets and liabilities are translated using the exchange rate on the balance sheet date, which was 0.6970 as of September 30, 2022. Revenue and expenses are translated using average exchange rates prevailing during each reporting period. The 0.7214 average exchange rates were used to translate revenues and expenses for the three months ended December 31, 2022. Stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive loss in stockholders’ deficit.

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. The resulting exchange difference, presented as foreign currency transaction loss, is included in the accompanying consolidated statements of operations.

 

Business Segments

 

The Company operates in only one segment.

 

6

 

 

Net Income (Loss) Per Share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. There were no potential dilutive debt or equity instruments issued and outstanding at any time during the three months ended December 31, 2023 and 2022.

 

Discounts on Common Stock

 

Common stock issued lower than the Company’s par value is treated as common stock issued under discounts. The portion of the discount is shown separately as a deduction from the Company’s account of common stock on the Company’s consolidated financial statements.

 

Stock-Based Compensation

 

The Company accounts for its stock-based compensation in which the Company obtains employee services in share-based payment transactions under FASB ASC Topic 718, Compensation – Stock Compensation, which requires the Company to expense the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized.

 

The Company considers positive and negative evidence when determining whether a portion or all of its deferred tax assets will more likely than not be realized. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, its experience with tax attributes expiring unused, and its tax planning strategies. The ultimate realization of deferred tax assets is dependent upon its ability to generate sufficient future taxable income within the carry-forward periods provided for in the tax law and during the periods in which the temporary differences become deductible. When assessing the realization of deferred tax assets, the Company has considered possible sources of taxable income including (i) future reversals of existing taxable temporary differences, (ii) future taxable income exclusive of reversing temporary differences and carry-forwards, (iii) future taxable income arising from implementing tax planning strategies, and (iv) specific known trend of profits expected to be reflected within the industry.

 

The Company recognizes a tax benefit associated with an uncertain tax position when, in its judgment, it is more likely than not that the position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The Company’s liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. The Company’s effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company classifies interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense.

 

There were no current and deferred income tax provision recorded for the three months ended December 31, 2023 and 2022 since the Company has recurring losses.

 

7

 

 

Recent Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs” or “ASU”) on the Company’s consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s consolidated financial position or results of operations. Recently issued ASUs that the Company feels may be applicable to the Company are as follows:

 

In August 2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU addresses complex financial instruments that have characteristics of both debt and equity. The application of this ASU would reduce the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models would result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. To date, no such bifurcation has been necessary. Management is evaluating the potential impact. This ASU becomes effective for fiscal years beginning after December 15, 2023.

 

NOTE 3 – GOING CONCERN

 

As of December 31, 2023 and September 30, 2023, the Company had an accumulated deficit of $10,601,201 and $10,503,191, respectively. To date, the Company’s cash flow requirements have been primarily met through proceeds received from sales of its common stock. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.

 

The Company received $362,000 from private placement during the year ended September 30, 2023. The proceeds have been used for operation expenses. Management is currently seeking additional funds for future operation.

 

NOTE 4 – EQUIPMENT

 

As of December 31, 2023 and September 30, 2023 the Company had equipment of $96,142 and $67,451, respectively, consisting of equipment to be installed at its electric vehicle charging stations and related installation costs.

 

NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

The Company is authorized under its articles of incorporation, as amended, to issue 10,000,000,000 shares of Common Stock, par value $0.001 per share.

 

On February 24, 2023, the Company conducted a private placement offering and sold 375,000,000 shares of common stock at $0.001 per share, for gross proceeds of $375,000, and incurred offering costs of $13,000.

 

On March 24, 2023, the Company issued 134,213,120 shares of common stock to its board of directors, officers, and former officers to repay the compensation due to them in the aggregate amount of $134,213 at the conversion rate of $0.001 per share.

 

Stock Options

 

On July 15, 2022, the CEO, David Tang, was granted 15,000,000 options to purchase shares at $0.01 per share. As of December 31, 2023, total options granted was 15,000,000 and 5,312,500 was vested. This option will be subject to a vesting schedule providing for twenty-five percent (25%) vesting after the first twelve (12) months of employment and monthly vesting as to the remaining seventy-five percent (75%) of the shares over the following thirty-six (36) months after the first anniversary of the employment commencement date. These stock options are exercisable over a maximum period of 10 years from the grant date. The weighted average grant date fair value of options granted during the year ended September 30, 2022 was $0.02.

 

Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair value of these options, over the requisite service period, or vesting period. Accordingly, the Company recognized stock-based compensation expense of $18,750 and $18,750, respectively, which was included in the general and administrative expenses in the consolidated statements of operations for the three months ended December 31, 2023 and 2022.

 

8

 

 

The fair value of the stock options listed above was determined using the Black-Scholes option pricing model with the following assumptions:

 

   December 31,
2023
 
Risk-free interest rate   2.99%
Expected term   6.08 years 
Expected volatility   379.35%
Expected dividend yield   0%

 

The following is a summary of the option activity for the three months ended December 31, 2023:

 

Options  Number of
Underlying
Shares
   Weighted
average
exercise
price
   Weighted
Average
Remaining
Contractual
Life (years)
   Aggregate
Intrinsic
Value
 
Outstanding at October 1, 2023   15,000,000   $0.01    
   $
 
Granted   
   $
       $ 
Exercised   
   $
       $ 
Forfeited or expired   
   $
       $ 
Outstanding at December 31, 2023   15,000,000   $0.01    8.5   $
 
Vested and expected to vest as of December 31, 2023   15,000,000   $0.01    8.5   $
 
Exercisable at December 31, 2023   5,312,500   $0.01    8.5   $
 

 

As of December 31, 2023, unrecognized total compensation cost associated with these options was $190,428. This expense is expected to be recognized over a weighted-average period of 2.54 years.

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

Related Parties

 

Name of related parties   Relationship with the Company
Yi Lung (Oliver) Lin   Principal shareholder
Jui Pin (John) Lin   Principal shareholder, Chairman of the Board, President, and Director
Jia Tian (Jeffery) Lin   Former Chief Executive Officer
Wen-Piao (Jack) Lai   Director
Shao-Cheng (Will) Wang   Former Chief Financial Officer
Kuang Ming (James) Tsai   Director and Chief Financial Officer
Hsin-Ta (Darren) Su   Director, Treasurer
Hui-Chuan (Sandra) Lin   Director and Secretary, daughter of Jui Pin (John) Lin
David Tang   Chief Executive Officer

 

Due to Related Parties

 

The Company’s due to related parties balances are as follows:

 

   December 31,
2023
   September 30,
2023
 
Hsin-Ta (Darren) Su  $1,496   $707 
David Tang   2,941    14,023 
Total  $4,437   $14,730 

 

The related party balances are unsecured, interest-free and due on demand.

 

9

 

 

NOTE 7 – INCOME TAXES

 

The Company has not generated any revenue from any source in the United States and had consolidated net loss for all the years since inception in 2010. Management believes GEEC does not have any U.S. income tax liability due. However, even though the Company does not have U.S. income tax liability, it may be required to file Form 5471 each year with the Internal Revenue Service (the “IRS”) of Department of Treasury. GEEC falls in the Category Five Filer (as a domestic corporation). The Company used to have subsidiaries: GEECIS in Sri Lanka that was established in May 2011, GESPL in Singapore that was established in February 2012, and GESTL in Thailand that was established in December 2014. The subsidiaries in Sri Lanka and Thailand were disposed in 2014 and 2016, respectively. The Singapore subsidiary has been inactive since 2016 and dissolved in January 2023.

 

Internal Revenue Code (“IRC”) Section 6038(a) requires information reporting with respect to certain foreign corporations (Form 5471) and describes the information required to be reported on this form. IRC Section 6038(b)(1) provides for a monetary penalty of $10,000 for each Form 5471 that is filed after the due date of the income tax return (including extensions) or does not include the complete and accurate information described in Section 6038(a). According to IRS rules, a penalty may apply to each Form 5471 which is filed after the due date of the income tax return. The penalty will be applied whether or not any tax is due on Form 1120.

 

The Company believes that based on the current information available, it is difficult to determine whether it is probable that the Company will be charged penalties by IRS for the late filing of Form 5471 and even if it will be, it is difficult to reasonably estimate the amount of penalties that may be assessed.

 

During the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30, 2020. The Company has engaged an outside professional advisor to seek for forgiveness of the penalty and interest thereon in the amount of $7,976, for a total of $32,976, which was still pending as of December 31, 2023.

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company terminated its previous virtual office agreement in Los Angeles, California and has established a new virtual office in Arcadia, California. The new arrangement is on a month-to-month basis at a cost of $200 per month. As of December 31, 2023, the Company has no material commitments under operating leases.

 

During the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30, 2020 (see Note 7).

 

NOTE 9 – SUBSEQUENT EVENTS

 

Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date when the consolidated financial statements were issued and determined that no subsequent events occurred that would require adjustment to or disclosure in the consolidated financial statements.

 

10

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing.

 

Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect”, “anticipate”, “hope” or other similar words. These forward-looking statements present our estimates and assumptions only as of the date of this report. Except for our ongoing obligation to disclose material information as required by the federal securities laws, we do not intend, and undertake no obligation, to update any forward-looking statement.

 

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. Some of the key factors impacting these risks and uncertainties include, but are not limited to:

 

risks related to our ability to identify, pursue and commence a reverse merger and/or a possible operating business;

 

our ability to obtain adequate funding to complete a reverse merger or commence a possible operating business and meet our operating expenses on a current basis;

 

general economic uncertainty, whether as a result of the COVID-19 pandemic or otherwise;

 

delays in our ability to obtain any necessary business licenses and permits, and commence business operations, whether as a result of the COVID-19 pandemic or otherwise; and

 

current and longer-term economic and other impacts of the COVID-19 pandemic on our operations, results of operations and financial condition, including without limitation changes in consumer spending patterns for non-essential products, resulting from the economic crisis caused by lockdown, shelter-in-place, stay-at-home or similar orders instituted as a result of the pandemic, or otherwise.

 

Overview

 

On August 1, 2022, the board of directors (the “Board”) of the Company unanimously approved to expand our business in the area of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such industry. On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless technology and carbon-neutral vehicle-charging infrastructure.

 

On October 26, 2022, we entered into three Charging Station Site Host Agreements (the “Agreements”) with two institutions (the “Site Hosts”), respectively, pursuant to which the Site Hosts agree to allow us to install our electric vehicle charging stations at the locations set forth in the Agreements (the “Charging Stations”). Under the Agreements, we have agreed to share our revenue generated by the sales of electricity at the Charging Stations with the Site Hosts in accordance with the schedules set forth therein.

 

As of December 31, 2022, the Company has purchased certain electric vehicle charging equipment. Furthermore, the Company is in the process of obtaining permits to construct the Charging Stations at the three confirmed sites. As of December 31, 2022, the Company contracted an architectural firm on providing design and engineering services for the two sites and working on technical issues for the third site.

 

As of February 13, 2023, the Company has received the finalized site plans and electrical diagrams from the architectural firm and electrical engineers for 2 sites. The Company has also received permission from the site owners to proceed with the charging station construction permit applications with the local municipalities. The Company expects to install up to a total of 10 charging units for the first two sites and expects to have them operational in early 2024.

 

11

 

 

Results of Operations

 

Three Months Ended December 31, 2023 compared to the Three Months Ended December 31, 2022

 

Revenues

 

We did not generate any revenues during the three months ended December 31, 2023 and 2022.

 

Operating Expenses

 

We incurred total operating expenses of $95,616 and $148,995 for the three months ended December 31, 2023 and 2022, respectively. Our operating expenses consist of business development expenses, legal fees, other professional fees, payroll expenses, stock-based compensation, rent, bank charges, and transfer agent fees. The decrease in operating expenses for the three months ended December 31, 2023 compared to the same period ended in 2022 was primarily due to decrease in payroll expenses.

 

Other expense

 

During the three months ended December 31, 2023, we incurred $794 other expenses mainly due to interest incurred for unpaid penalty from IRS. During the three months ended December 31, 2022, we incurred $793 other expenses mainly due to interest incurred for unpaid penalty from IRS.

 

Net Loss

 

As a result of the above, our net loss decreased from $149,788 in the three months ended December 31, 2022 to $98,010 in the same period ended in 2023.

 

Liquidity and Capital Resources

 

Working Capital

 

   December 31,   September 30, 
   2023   2023 
Current Assets  $27,617   $134,111 
Current Liabilities   116,323    115,616 
Working Capital (Deficit)  $(88,706)  $18,495 

 

As of December 31, 2023, we had current assets of $27,617 and a working capital deficit of $88,706. In comparison, as of September 30, 2023, we had current assets of $134,111 and a working capital surplus of $18,495.

 

We had $116,323 in total current liabilities as of December 31, 2023, consisting of $111,849 in accounts payable, $37 in accrued expenses, and $4,437 due to related parties. This is compared to total current liabilities of $115,616 in total current liabilities as of September 30, 2023, consisting of $100,849 in accounts payable, $37 in accrued expenses, and $14,730 in due to related parties. The decrease in due to related parties was primarily due to unpaid compensation to officers and directors repaid.

 

We had total stockholders’ deficit of $25,540 and an accumulated deficit of $10,601,201 as of December 31, 2023. In comparison, we had a total stockholders’ equity of $53,720 and an accumulated deficit of $10,503,191 as of September 30, 2023.

 

12

 

 

Cash Flows

 

   Three months
ended
December 31,
2023
   Three months
ended
December 31,
2022
 
Cash flows used in operating activities  $(77,616)  $(74,869)
Cash flows used in investing activities   (28,691)   (15,005)
Cash flows provided by financing activities   -    - 
Effect of exchange rate changes on cash   -    - 
Net decrease in cash during period  $(106,307)  $(89,874)

 

During the three months ended December 31, 2023, we used $77,616 of cash in operating activities which was attributable primarily to our net loss of $98,010 offset by stock-based compensation, and change in operating assets and liabilities of $20,394. In comparison, during the three months ended December 31, 2022, we used $74,869 of cash in operating activities which was attributable primarily to our net loss of $149,788 offset by stock-based compensation and change in operating assets and liabilities of $74,919.

 

During the three months ended December 31, 2023, we used $28,691 of cash investing activity in purchase of equipment. During the three months ended December 31, 2022, we used $15,005 of cash investing activity in purchase of equipment.

 

During the three months ended December 31, 2023 and 2022, we did not have any financing activity.

 

There is substantial doubt that we can continue as an ongoing business for the next twelve months unless we obtain additional capital to pay our expenses as they become due. We do not anticipate any significant additional revenue until and unless we begin to execute our plan of operations involving the start of our new electric vehicle charging station business. There is no assurance that we will ever reach that stage. The condensed consolidated financial statements presented herein do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that we cannot continue as a going concern.

 

Our ability to continue as a going concern is dependent upon our ability to successfully execute our business plan and generate profitable operations in the future, and, until and unless we achieve that, to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal business operation as and when they become due. To date, our capital requirements have primarily been funded by shareholders through the purchase of our Common Stock in private offerings and short-term borrowings from a former officer and another shareholder.

 

Contractual Obligations

 

We do not have material contractual obligations and commitments. We only have one lease that is renewed on a month-to-month basis.

 

13

 

 

Off-Balance Sheet Arrangements

 

As of December 31, 2023, we had not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. As of December 31, 2023, we had not entered into any derivative contracts that are indexed to our shares and classified as shareholder’s equity or that are not reflected in our condensed consolidated financial statements. Furthermore, as of December 31, 2023, we had not had any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. As of December 31, 2023, we had not had any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

 

Critical accounting policies and estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We continually evaluate our estimates, including those related to income taxes, and the valuation of equity transactions. We base our estimates on historical experience and on various other assumptions that we believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Any future changes to these estimates and assumptions could cause a material change to our reported amounts of revenues, expenses, assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. For the three months ended December 31, 2023, and 2022, no significant estimates and assumptions have been made in the condensed consolidated financial statements. The following are some of the critical accounting policies in relation to the preparation of the condensed consolidated financial statements. For a full summary of our critical accounting policies, please refer to Note 2 to the Consolidated Financial Statements.

 

Stock-Based Compensation

 

We account for stock-based compensation in which we obtain employee services in share-based payment transactions under FASB ASC Topic 718, Compensation – Stock Compensation, which requires us to expense the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.

 

Recent accounting pronouncements

 

We do not expect that the adoption of recently issued accounting pronouncements will have a material impact on our financial position, results of operations, or cash flows. For a full summary of recent accounting pronouncements, please refer to Note 2 to the Consolidated Financial Statements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

 

Not required for smaller reporting companies.

 

14

 

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Our disclosure controls and procedures are designed to ensure that the information relating to our Company, including our consolidated subsidiary, required to be disclosed in our reports filed with the Securities and Exchange Commission (the “SEC”) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow for timely decisions regarding required disclosure. We conducted an evaluation, under the supervision and with the participation of management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this annual report. Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of the evaluation date, our disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting, as described below.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of management, including our chief executive officer and chief financial officer, we conducted an evaluation of the design and operating effectiveness of our internal controls over financial reporting based on the framework in “Internal Control-Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the consolidated financial statements.

 

Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023 and identified the following material weaknesses:

 

Inadequate Segregation of Duties: We have an inadequate number of personnel to properly implement control procedures.

 

Comingling of funds: We do not have adequate control of our petty cash, resulting in the comingling of our petty cash with the nominal account holder’s personal funds.

 

Lack of Adequate Staffing: We do not have adequate in-house accounting personnel and expertise in key positions, which resulted in overly relying on outside consultants in preparing financial statements and other required disclosures by the Securities and Exchange Commission.

 

Ineffective oversight: We do not exercise effective oversight and monitoring procedures designed and implemented to certain control activities.

 

Overly relied on outside professionals: We are unable to prepare internally financial statements and relied on outside professional consultants to prepare financial statements and adequate disclosures.

 

15

 

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. As a result of the material weaknesses in internal control over financial reporting identified above, management concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2023, based on the criteria set forth in “Internal Control-Integrated Framework” issued by COSO.

 

Due to the nature of the material weaknesses, there is a more than remote likelihood that misstatements which could be material to the annual or interim financial statements could occur that would not be prevented or detected. The material weaknesses identified above either individually or in aggregation did not result in any identified misstatements or errors in the Company’s condensed consolidated financial statements at and for the three-month period ended December 31, 2023.

 

Management’s Plan for Remediation

 

Management has discussed the material weaknesses noted above with our independent registered public accounting firm. Management is committed to improving its internal controls and, subject to having adequate financial resources, intends to:

 

increase the frequency of independent reconciliations of significant accounts which will mitigate the lack of segregation of duties to monitor and review until there are sufficient personnel to segregate duties;

 

consider providing professional courses for our key position personnel;

 

hire additional employees to realize segregation of duties; and

 

strengthen management monitoring control over accounting and financial statements preparation processing.

 

However, due to limitation of funds and personnel, we have so far been unable to begin to implement the plan to remediate the material weaknesses noted above and it is uncertain when we will be able to begin to implement the plan to remediate these material weaknesses.

 

Inherent Limitations on Effectiveness of Controls

 

A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all control issues or misstatements. Accordingly, our controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our control system are met. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become adequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Changes in Internal Control

 

There have been no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

16

 

 

PART II

OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are not currently a party to any lawsuit or proceeding, which, in the opinion of management, is likely to have a material adverse effect on us or our business.

 

ITEM 1A. RISK FACTORS

 

Not required of smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

17

 

 

ITEM 6. EXHIBITS

 

Exhibit No.   Description
31.1   Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934.
31.2   Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and Rules 13a-14 and 15d-14 under the Securities Exchange Act of 1934.
32.1*   Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*The certifications attached as Exhibits 32.1 and 32.2 accompany this quarterly report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

18

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GENUFOOD ENERGY ENZYMES CORP.
     
Date: February 20, 2024 By: /s/ David Tang
    David Tang
    Chief Executive Officer
   
  By: /s/ Kuang Ming (James) Tsai
    Kuang Ming (James) Tsai
    Director, Chief Financial Officer

 

 

19

 

NONE Yes Yes 299686921 808900041 false --09-30 Q1 2024 false 0001510518 00-0000000 true 0001510518 2023-10-01 2023-12-31 0001510518 2024-02-15 0001510518 2023-12-31 0001510518 2023-09-30 0001510518 us-gaap:RelatedPartyMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember 2023-09-30 0001510518 2022-10-01 2022-12-31 0001510518 us-gaap:CommonStockMember 2023-09-30 0001510518 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001510518 gfoo:DiscountOnCommonStockMember 2023-09-30 0001510518 us-gaap:RetainedEarningsMember 2023-09-30 0001510518 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001510518 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001510518 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001510518 gfoo:DiscountOnCommonStockMember 2023-10-01 2023-12-31 0001510518 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001510518 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0001510518 us-gaap:CommonStockMember 2023-12-31 0001510518 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001510518 gfoo:DiscountOnCommonStockMember 2023-12-31 0001510518 us-gaap:RetainedEarningsMember 2023-12-31 0001510518 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001510518 gfoo:RestatedMember us-gaap:CommonStockMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001510518 gfoo:RestatedMember gfoo:DiscountOnCommonStockMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:RetainedEarningsMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001510518 gfoo:RestatedMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember gfoo:DiscountOnCommonStockMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:CommonStockMember 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001510518 gfoo:RestatedMember gfoo:DiscountOnCommonStockMember 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:RetainedEarningsMember 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001510518 gfoo:RestatedMember 2022-12-31 0001510518 2022-09-30 0001510518 2022-12-31 0001510518 2022-10-01 2023-09-30 0001510518 2023-02-24 0001510518 2023-02-24 2023-02-24 0001510518 2023-03-24 0001510518 2023-03-24 2023-03-24 0001510518 srt:ChiefExecutiveOfficerMember 2022-07-15 2022-07-15 0001510518 srt:ChiefExecutiveOfficerMember 2022-07-15 0001510518 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-12-31 0001510518 us-gaap:StockOptionMember gfoo:VestingMember 2023-10-01 2023-12-31 0001510518 gfoo:VestingMember 2023-10-01 2023-12-31 0001510518 us-gaap:StockOptionMember 2023-10-01 2023-12-31 0001510518 us-gaap:StockOptionMember 2021-10-01 2022-09-30 0001510518 gfoo:YiLungOliverLinMember 2023-10-01 2023-12-31 0001510518 gfoo:JuiPinJohnLinMember 2023-10-01 2023-12-31 0001510518 gfoo:JiaTianJefferyLinMember 2023-10-01 2023-12-31 0001510518 gfoo:WenPiaoJackLaiMember 2023-10-01 2023-12-31 0001510518 gfoo:ShaoChengWillWangMember 2023-10-01 2023-12-31 0001510518 gfoo:KuangMingJamesTsaiMember 2023-10-01 2023-12-31 0001510518 gfoo:HsinTaDarrenSuMember 2023-10-01 2023-12-31 0001510518 gfoo:HuiChuanSandraLinMember 2023-10-01 2023-12-31 0001510518 gfoo:DavidTangMember 2023-10-01 2023-12-31 0001510518 us-gaap:RelatedPartyMember gfoo:HsinTaDarrenSuMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember gfoo:HsinTaDarrenSuMember 2023-09-30 0001510518 us-gaap:RelatedPartyMember gfoo:DavidTangMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember gfoo:DavidTangMember 2023-09-30 0001510518 us-gaap:RelatedPartyMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember 2023-09-30 0001510518 2021-09-30 0001510518 2019-10-01 2020-09-30 0001510518 2020-10-01 2021-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q1223ex31-1_genufood.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

 

I, David Tang, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Genufood Energy Enzymes Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15-d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 20, 2024  
   
By: /s/ David Tang  
Name:  David Tang  
Title: Chief Executive Officer  
  (principal executive officer)  

 

EX-31.2 3 f10q1223ex31-2_genufood.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION

 

I, Kuang Ming (James) Tsai, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Genufood Energy Enzymes Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15-d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 20, 2024  
     
By: /s/ Kuang Ming (James) Tsai  
Name:  Kuang Ming (James) Tsai  
Title: Director, Chief Financial Officer  
  (principal financial officer and  
  principal accounting officer)  

 

EX-32.1 4 f10q1223ex32-1_genufood.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION

 

In connection with the quarterly report of Genufood Energy Enzymes Corp. (the “Company”) on Form 10-Q for the quarter ended December 31, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, David Tang, Chief Executive Officer (Principal Executive Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

Date: February 20, 2024  
   
By: /s/ David Tang  
Name:  David Tang  
Title: Chief Executive Officer  
  (principal executive officer)  

 

This certification is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

EX-32.2 5 f10q1223ex32-2_genufood.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION

 

In connection with the quarterly report of Genufood Energy Enzymes Corp. (the “Company”) on Form 10-Q for the quarter ended December 31, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Kuang Ming (James) Tsai, Director, Chief Financial Officer (Principal Financial Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

Date: February 20, 2024  
   
By: /s/ Kuang Ming (James) Tsai  
Name:  Kuang Ming (James) Tsai  
Title: Director, Chief Financial Officer  
  (principal financial officer and  
  principal accounting officer)  

 

This certification is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-101.SCH 6 gfoo-20231231.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consoildated Statements of Stockholders’ Equity (Deficit) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - General Organization and Business link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Equipment link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Stockholders’ Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Stockholders’ Equity (Deficit) (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Stockholders’ Equity (Deficit) (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Stockholders’ Equity (Deficit) (Details) - Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Stockholders’ Equity (Deficit) (Details) - Schedule of Option Activity link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Related Party Transactions (Details) - Schedule of Related Parties Name and Relationship link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Related Party Transactions (Details) - Schedule of Due to Related Parties Balances link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 gfoo-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 gfoo-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 gfoo-20231231_lab.xml XBRL LABEL FILE EX-101.PRE 10 gfoo-20231231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information - shares
3 Months Ended
Dec. 31, 2023
Feb. 15, 2024
Document Information Line Items    
Entity Registrant Name GENUFOOD ENERGY ENZYMES CORP.  
Document Type 10-Q  
Current Fiscal Year End Date --09-30  
Entity Common Stock, Shares Outstanding   808,900,041
Amendment Flag false  
Entity Central Index Key 0001510518  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Dec. 31, 2023  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Entity File Number 000-56112  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 1108 S. Baldwin Avenue  
Entity Address, Address Line Two Suite 107  
Entity Address, City or Town Arcadia  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 91007  
City Area Code (855)  
Local Phone Number 707-2077  
Title of 12(b) Security N/A  
Security Exchange Name NONE  
Entity Interactive Data Current Yes  
Document Transition Report false  
Entity Tax Identification Number 00-0000000  
No Trading Symbol Flag true  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Sep. 30, 2023
Current assets    
Cash and cash equivalents $ 19,617 $ 125,924
Prepayment 8,000 8,187
Total Current Assets 27,617 134,111
Equipment 96,142 67,451
Total Assets 123,759 201,562
Current liabilities    
Accounts payable 111,849 100,849
Accrued expenses 37 37
Total Current Liabilities 116,323 115,616
Commitment and contingencies (Note 8) 32,976 32,226
Stockholders’ (Deficit) Equity    
Common stock: $0.001 par value; 10,000,000,000 shares authorized; 808,900,041 shares issued and outstanding as of December 31, 2023 and September 30, 2023 808,900 808,900
Additional paid-in capital 17,008,342 16,989,592
Discount on common stock (7,241,581) (7,241,581)
Accumulated deficit (10,601,201) (10,503,191)
Total Stockholders’ (Deficit) Equity (25,540) 53,720
Total Liabilities and Stockholders’ (Deficit) Equity 123,759 201,562
Related Party    
Current liabilities    
Due to related parties $ 4,437 $ 14,730
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2023
Sep. 30, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 10,000,000,000 10,000,000,000
Common stock, shares issued 808,900,041 808,900,041
Common stock, shares outstanding 808,900,041 808,900,041
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue
Operating expenses    
General and administrative expenses 95,616 148,995
Total operating expenses 95,616 148,995
Loss from operations (95,616) (148,995)
Other income (expense)    
Interest expense (44)
Foreign currency loss (43)
Other non-operating income (expenses), net (750) (750)
Total other (expense) income (794) (793)
Loss before income taxes (96,410) (149,788)
Provision for income taxes 1,600
Net loss (98,010) (149,788)
Other comprehensive income (loss)    
Foreign currency transaction adjustment (85)
Comprehensive loss $ (98,010) $ (149,873)
Loss per share of common stock - basic (in Dollars per share) [1]
Weighted average shares outstanding - basic (in Shares) 808,900,041 299,686,921
[1] Less than $0.01 per share
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals) - $ / shares
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Loss per share of common stock - diluted [1]
Weighted average shares outstanding - diluted 808,900,041 299,686,921
[1] Less than $0.01 per share
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consoildated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Restated
Common Stock
Restated
Additional Paid-in- Capital
Restated
Discount on common stock
Restated
Accumulated Deficit
Restated
Accumulated Other Comprehensive Income (loss)
Restated
Common Stock
Additional Paid-in- Capital
Discount on common stock
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Total
Balance at Sep. 30, 2022 $ 299,687 $ 16,927,592 $ (7,241,581) $ (9,875,489) $ (193,558) $ (83,349)            
Balance (in Shares) at Sep. 30, 2022 299,686,921                      
Stock-based compensation 18,750 18,750            
Foreign currency translation (85) (85)            
Net Loss (149,788) (149,788)           $ (149,788)
Balance at Dec. 31, 2022 $ 299,687 $ 16,946,342 $ (7,241,581) $ (10,025,277) $ (193,643) $ (214,472)            
Balance (in Shares) at Dec. 31, 2022 299,686,921                      
Balance at Sep. 30, 2023             $ 808,900 $ 16,989,592 $ (7,241,581) $ (10,503,191) 53,720
Balance (in Shares) at Sep. 30, 2023             808,900,041          
Stock-based compensation             18,750 18,750
Net Loss             (98,010) (98,010)
Balance at Dec. 31, 2023             $ 808,900 $ 17,008,342 $ (7,241,581) $ (10,601,201) $ (25,540)
Balance (in Shares) at Dec. 31, 2023             808,900,041          
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities    
Net loss $ (98,010) $ (149,788)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 18,750 18,750
Change in operating assets and liabilities    
Prepayment 187 7,836
Accounts payable 11,000 17,401
Due to related parties (10,293) 30,182
Commitment and contingencies 750 750
Net cash used in operating activities (77,616) (74,869)
Cash Flows from Investing Activities    
Purchase of equipment (28,691) (15,005)
Net cash used in investing activities (28,691) (15,005)
Net decrease in cash and cash equivalents (106,307) (89,874)
Cash and cash equivalents, beginning of period 125,924 136,400
Cash and cash equivalents, end of period 19,617 46,526
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest
Cash paid for income taxes $ 1,600
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
General Organization and Business
3 Months Ended
Dec. 31, 2023
General Organization and Business [Abstract]  
GENERAL ORGANIZATION AND BUSINESS

NOTE 1 – GENERAL ORGANIZATION AND BUSINESS

 

Genufood Energy Enzymes Corp., USA (the “Company” or “GEEC”) was incorporated under the laws of the State of Nevada on June 21, 2010. On February 13, 2012, GEEC incorporated a wholly-owned subsidiary, Genufood Enzymes (S) Pte Ltd (“GESPL”) in Singapore, which was dissolved on January 9, 2023.

 

Since its inception, the Company has always been in the development stage and never generated significant revenues. The Company is currently developing business in Electric Vehicle Charge station. The Company has engaged in business agreements and development with various parties. The Company has initiated its electric vehicle charging station business.

 

On August 1, 2022, the board of directors (the “Board”) of the Company unanimously approved to expand our business in the area of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such industry. On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless technology and carbon-neutral vehicle-charging infrastructure.

 

On October 26, 2022, the Company entered into three Charging Station Site Host Agreements (the “Agreements”) with two institutions (the “Site Hosts”), respectively, pursuant to which the Site Hosts agree to allow the Company to install its electric vehicle charging stations at the locations set forth in the Agreements (the “Charging Stations”). Under the Agreements, the Company has agreed to share the revenue generated by the sales of electricity at the Charging Stations with the Site Hosts.

 

As of December 31, 2023, the Company has two sites under construction for charging stations and three sites under planning.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies
3 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company’s condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending September 30, 2024. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023.

 

Principle of Consolidation

 

The condensed consolidated financial statements include the accounts of GEEC and its wholly-owned subsidiary GESPL. All significant inter-company accounts and transactions have been eliminated in consolidation. The wholly-owned subsidiary of the Company did not have business activities prior to its dissolution.

 

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, to the extent balances exceeded limits that were insured by the Federal Deposit Insurance Corporation. The Company does not require collateral and maintains reserves for potential credit losses. Such losses have historically been immaterial and have been within management’s expectations.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid instruments with original maturities of three months or less when acquired to be cash equivalents. As of December 31, 2023 and September 30, 2023, the Company did not have cash equivalents.

 

Fair Value of Financial Instruments

 

The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1 inputs are quoted prices available for identical assets and liabilities in active markets.
     
  Level 2 inputs are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets or other inputs that are observable or can be corroborated by observable market data.
     
  Level 3 inputs are less observable and reflect our own assumptions.

 

The Company’s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued expenses and due to related parties. The carrying amounts of such financial instruments in the accompanying consolidated balance sheets approximate their fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.

 

Foreign Currency Translation and Transactions

 

The reporting and functional currency of GEEC is the USD. The functional currency of GESPL, a wholly owned subsidiary of GEEC, is the Singapore Dollar (“SGD”).

 

For financial reporting purposes, the financial statements of the Company’s Singapore subsidiary, which are prepared using the SGD, are translated into the Company’s reporting currency, USD. Assets and liabilities are translated using the exchange rate on the balance sheet date, which was 0.6970 as of September 30, 2022. Revenue and expenses are translated using average exchange rates prevailing during each reporting period. The 0.7214 average exchange rates were used to translate revenues and expenses for the three months ended December 31, 2022. Stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive loss in stockholders’ deficit.

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. The resulting exchange difference, presented as foreign currency transaction loss, is included in the accompanying consolidated statements of operations.

 

Business Segments

 

The Company operates in only one segment.

 

Net Income (Loss) Per Share

 

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. There were no potential dilutive debt or equity instruments issued and outstanding at any time during the three months ended December 31, 2023 and 2022.

 

Discounts on Common Stock

 

Common stock issued lower than the Company’s par value is treated as common stock issued under discounts. The portion of the discount is shown separately as a deduction from the Company’s account of common stock on the Company’s consolidated financial statements.

 

Stock-Based Compensation

 

The Company accounts for its stock-based compensation in which the Company obtains employee services in share-based payment transactions under FASB ASC Topic 718, Compensation – Stock Compensation, which requires the Company to expense the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized.

 

The Company considers positive and negative evidence when determining whether a portion or all of its deferred tax assets will more likely than not be realized. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, its experience with tax attributes expiring unused, and its tax planning strategies. The ultimate realization of deferred tax assets is dependent upon its ability to generate sufficient future taxable income within the carry-forward periods provided for in the tax law and during the periods in which the temporary differences become deductible. When assessing the realization of deferred tax assets, the Company has considered possible sources of taxable income including (i) future reversals of existing taxable temporary differences, (ii) future taxable income exclusive of reversing temporary differences and carry-forwards, (iii) future taxable income arising from implementing tax planning strategies, and (iv) specific known trend of profits expected to be reflected within the industry.

 

The Company recognizes a tax benefit associated with an uncertain tax position when, in its judgment, it is more likely than not that the position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The Company’s liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. The Company’s effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company classifies interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense.

 

There were no current and deferred income tax provision recorded for the three months ended December 31, 2023 and 2022 since the Company has recurring losses.

 

Recent Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs” or “ASU”) on the Company’s consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s consolidated financial position or results of operations. Recently issued ASUs that the Company feels may be applicable to the Company are as follows:

 

In August 2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU addresses complex financial instruments that have characteristics of both debt and equity. The application of this ASU would reduce the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models would result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. To date, no such bifurcation has been necessary. Management is evaluating the potential impact. This ASU becomes effective for fiscal years beginning after December 15, 2023.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
Going Concern
3 Months Ended
Dec. 31, 2023
Going Concern [Abstract]  
GOING CONCERN

NOTE 3 – GOING CONCERN

 

As of December 31, 2023 and September 30, 2023, the Company had an accumulated deficit of $10,601,201 and $10,503,191, respectively. To date, the Company’s cash flow requirements have been primarily met through proceeds received from sales of its common stock. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.

 

The Company received $362,000 from private placement during the year ended September 30, 2023. The proceeds have been used for operation expenses. Management is currently seeking additional funds for future operation.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equipment
3 Months Ended
Dec. 31, 2023
Equipment [Abstract]  
EQUIPMENT

NOTE 4 – EQUIPMENT

 

As of December 31, 2023 and September 30, 2023 the Company had equipment of $96,142 and $67,451, respectively, consisting of equipment to be installed at its electric vehicle charging stations and related installation costs.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity (Deficit)
3 Months Ended
Dec. 31, 2023
Stockholders’ Equity (Deficit) [Abstract]  
STOCKHOLDERS’ EQUITY (DEFICIT)

NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

The Company is authorized under its articles of incorporation, as amended, to issue 10,000,000,000 shares of Common Stock, par value $0.001 per share.

 

On February 24, 2023, the Company conducted a private placement offering and sold 375,000,000 shares of common stock at $0.001 per share, for gross proceeds of $375,000, and incurred offering costs of $13,000.

 

On March 24, 2023, the Company issued 134,213,120 shares of common stock to its board of directors, officers, and former officers to repay the compensation due to them in the aggregate amount of $134,213 at the conversion rate of $0.001 per share.

 

Stock Options

 

On July 15, 2022, the CEO, David Tang, was granted 15,000,000 options to purchase shares at $0.01 per share. As of December 31, 2023, total options granted was 15,000,000 and 5,312,500 was vested. This option will be subject to a vesting schedule providing for twenty-five percent (25%) vesting after the first twelve (12) months of employment and monthly vesting as to the remaining seventy-five percent (75%) of the shares over the following thirty-six (36) months after the first anniversary of the employment commencement date. These stock options are exercisable over a maximum period of 10 years from the grant date. The weighted average grant date fair value of options granted during the year ended September 30, 2022 was $0.02.

 

Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair value of these options, over the requisite service period, or vesting period. Accordingly, the Company recognized stock-based compensation expense of $18,750 and $18,750, respectively, which was included in the general and administrative expenses in the consolidated statements of operations for the three months ended December 31, 2023 and 2022.

 

The fair value of the stock options listed above was determined using the Black-Scholes option pricing model with the following assumptions:

 

   December 31,
2023
 
Risk-free interest rate   2.99%
Expected term   6.08 years 
Expected volatility   379.35%
Expected dividend yield   0%

 

The following is a summary of the option activity for the three months ended December 31, 2023:

 

Options  Number of
Underlying
Shares
   Weighted
average
exercise
price
   Weighted
Average
Remaining
Contractual
Life (years)
   Aggregate
Intrinsic
Value
 
Outstanding at October 1, 2023   15,000,000   $0.01    
   $
 
Granted   
   $
       $ 
Exercised   
   $
       $ 
Forfeited or expired   
   $
       $ 
Outstanding at December 31, 2023   15,000,000   $0.01    8.5   $
 
Vested and expected to vest as of December 31, 2023   15,000,000   $0.01    8.5   $
 
Exercisable at December 31, 2023   5,312,500   $0.01    8.5   $
 

 

As of December 31, 2023, unrecognized total compensation cost associated with these options was $190,428. This expense is expected to be recognized over a weighted-average period of 2.54 years.

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Party Transactions
3 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

Related Parties

 

Name of related parties   Relationship with the Company
Yi Lung (Oliver) Lin   Principal shareholder
Jui Pin (John) Lin   Principal shareholder, Chairman of the Board, President, and Director
Jia Tian (Jeffery) Lin   Former Chief Executive Officer
Wen-Piao (Jack) Lai   Director
Shao-Cheng (Will) Wang   Former Chief Financial Officer
Kuang Ming (James) Tsai   Director and Chief Financial Officer
Hsin-Ta (Darren) Su   Director, Treasurer
Hui-Chuan (Sandra) Lin   Director and Secretary, daughter of Jui Pin (John) Lin
David Tang   Chief Executive Officer

 

Due to Related Parties

 

The Company’s due to related parties balances are as follows:

 

   December 31,
2023
   September 30,
2023
 
Hsin-Ta (Darren) Su  $1,496   $707 
David Tang   2,941    14,023 
Total  $4,437   $14,730 

 

The related party balances are unsecured, interest-free and due on demand.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
3 Months Ended
Dec. 31, 2023
Income Taxes [Abstract]  
INCOME TAXES

NOTE 7 – INCOME TAXES

 

The Company has not generated any revenue from any source in the United States and had consolidated net loss for all the years since inception in 2010. Management believes GEEC does not have any U.S. income tax liability due. However, even though the Company does not have U.S. income tax liability, it may be required to file Form 5471 each year with the Internal Revenue Service (the “IRS”) of Department of Treasury. GEEC falls in the Category Five Filer (as a domestic corporation). The Company used to have subsidiaries: GEECIS in Sri Lanka that was established in May 2011, GESPL in Singapore that was established in February 2012, and GESTL in Thailand that was established in December 2014. The subsidiaries in Sri Lanka and Thailand were disposed in 2014 and 2016, respectively. The Singapore subsidiary has been inactive since 2016 and dissolved in January 2023.

 

Internal Revenue Code (“IRC”) Section 6038(a) requires information reporting with respect to certain foreign corporations (Form 5471) and describes the information required to be reported on this form. IRC Section 6038(b)(1) provides for a monetary penalty of $10,000 for each Form 5471 that is filed after the due date of the income tax return (including extensions) or does not include the complete and accurate information described in Section 6038(a). According to IRS rules, a penalty may apply to each Form 5471 which is filed after the due date of the income tax return. The penalty will be applied whether or not any tax is due on Form 1120.

 

The Company believes that based on the current information available, it is difficult to determine whether it is probable that the Company will be charged penalties by IRS for the late filing of Form 5471 and even if it will be, it is difficult to reasonably estimate the amount of penalties that may be assessed.

 

During the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30, 2020. The Company has engaged an outside professional advisor to seek for forgiveness of the penalty and interest thereon in the amount of $7,976, for a total of $32,976, which was still pending as of December 31, 2023.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments and Contingencies
3 Months Ended
Dec. 31, 2023
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company terminated its previous virtual office agreement in Los Angeles, California and has established a new virtual office in Arcadia, California. The new arrangement is on a month-to-month basis at a cost of $200 per month. As of December 31, 2023, the Company has no material commitments under operating leases.

 

During the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30, 2020 (see Note 7).

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Subsequent Events
3 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date when the consolidated financial statements were issued and determined that no subsequent events occurred that would require adjustment to or disclosure in the consolidated financial statements.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Accounting Policies, by Policy (Policies)
3 Months Ended
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The Company’s condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending September 30, 2024. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023.

Principle of Consolidation

Principle of Consolidation

The condensed consolidated financial statements include the accounts of GEEC and its wholly-owned subsidiary GESPL. All significant inter-company accounts and transactions have been eliminated in consolidation. The wholly-owned subsidiary of the Company did not have business activities prior to its dissolution.

Use of Estimates

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, to the extent balances exceeded limits that were insured by the Federal Deposit Insurance Corporation. The Company does not require collateral and maintains reserves for potential credit losses. Such losses have historically been immaterial and have been within management’s expectations.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid instruments with original maturities of three months or less when acquired to be cash equivalents. As of December 31, 2023 and September 30, 2023, the Company did not have cash equivalents.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

  Level 1 inputs are quoted prices available for identical assets and liabilities in active markets.
     
  Level 2 inputs are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets or other inputs that are observable or can be corroborated by observable market data.
     
  Level 3 inputs are less observable and reflect our own assumptions.

The Company’s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued expenses and due to related parties. The carrying amounts of such financial instruments in the accompanying consolidated balance sheets approximate their fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.

Foreign Currency Translation and Transactions

Foreign Currency Translation and Transactions

The reporting and functional currency of GEEC is the USD. The functional currency of GESPL, a wholly owned subsidiary of GEEC, is the Singapore Dollar (“SGD”).

For financial reporting purposes, the financial statements of the Company’s Singapore subsidiary, which are prepared using the SGD, are translated into the Company’s reporting currency, USD. Assets and liabilities are translated using the exchange rate on the balance sheet date, which was 0.6970 as of September 30, 2022. Revenue and expenses are translated using average exchange rates prevailing during each reporting period. The 0.7214 average exchange rates were used to translate revenues and expenses for the three months ended December 31, 2022. Stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive loss in stockholders’ deficit.

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. The resulting exchange difference, presented as foreign currency transaction loss, is included in the accompanying consolidated statements of operations.

Business Segments

Business Segments

The Company operates in only one segment.

 

Net Income (Loss) Per Share

Net Income (Loss) Per Share

The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. There were no potential dilutive debt or equity instruments issued and outstanding at any time during the three months ended December 31, 2023 and 2022.

Discounts on Common Stock

Discounts on Common Stock

Common stock issued lower than the Company’s par value is treated as common stock issued under discounts. The portion of the discount is shown separately as a deduction from the Company’s account of common stock on the Company’s consolidated financial statements.

Stock-Based Compensation

Stock-Based Compensation

The Company accounts for its stock-based compensation in which the Company obtains employee services in share-based payment transactions under FASB ASC Topic 718, Compensation – Stock Compensation, which requires the Company to expense the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.

Income Taxes

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized.

The Company considers positive and negative evidence when determining whether a portion or all of its deferred tax assets will more likely than not be realized. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, its experience with tax attributes expiring unused, and its tax planning strategies. The ultimate realization of deferred tax assets is dependent upon its ability to generate sufficient future taxable income within the carry-forward periods provided for in the tax law and during the periods in which the temporary differences become deductible. When assessing the realization of deferred tax assets, the Company has considered possible sources of taxable income including (i) future reversals of existing taxable temporary differences, (ii) future taxable income exclusive of reversing temporary differences and carry-forwards, (iii) future taxable income arising from implementing tax planning strategies, and (iv) specific known trend of profits expected to be reflected within the industry.

The Company recognizes a tax benefit associated with an uncertain tax position when, in its judgment, it is more likely than not that the position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The Company’s liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. The Company’s effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company classifies interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense.

There were no current and deferred income tax provision recorded for the three months ended December 31, 2023 and 2022 since the Company has recurring losses.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs” or “ASU”) on the Company’s consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s consolidated financial position or results of operations. Recently issued ASUs that the Company feels may be applicable to the Company are as follows:

In August 2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU addresses complex financial instruments that have characteristics of both debt and equity. The application of this ASU would reduce the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models would result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. To date, no such bifurcation has been necessary. Management is evaluating the potential impact. This ASU becomes effective for fiscal years beginning after December 15, 2023.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity (Deficit) (Tables)
3 Months Ended
Dec. 31, 2023
Stockholders’ Equity (Deficit) [Abstract]  
Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model The fair value of the stock options listed above was determined using the Black-Scholes option pricing model with the following assumptions:
   December 31,
2023
 
Risk-free interest rate   2.99%
Expected term   6.08 years 
Expected volatility   379.35%
Expected dividend yield   0%
Schedule of Option Activity The following is a summary of the option activity for the three months ended December 31, 2023:
Options  Number of
Underlying
Shares
   Weighted
average
exercise
price
   Weighted
Average
Remaining
Contractual
Life (years)
   Aggregate
Intrinsic
Value
 
Outstanding at October 1, 2023   15,000,000   $0.01    
   $
 
Granted   
   $
       $ 
Exercised   
   $
       $ 
Forfeited or expired   
   $
       $ 
Outstanding at December 31, 2023   15,000,000   $0.01    8.5   $
 
Vested and expected to vest as of December 31, 2023   15,000,000   $0.01    8.5   $
 
Exercisable at December 31, 2023   5,312,500   $0.01    8.5   $
 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Party Transactions (Tables)
3 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
Schedule of Related Parties Name and Relationship Related Parties
Name of related parties   Relationship with the Company
Yi Lung (Oliver) Lin   Principal shareholder
Jui Pin (John) Lin   Principal shareholder, Chairman of the Board, President, and Director
Jia Tian (Jeffery) Lin   Former Chief Executive Officer
Wen-Piao (Jack) Lai   Director
Shao-Cheng (Will) Wang   Former Chief Financial Officer
Kuang Ming (James) Tsai   Director and Chief Financial Officer
Hsin-Ta (Darren) Su   Director, Treasurer
Hui-Chuan (Sandra) Lin   Director and Secretary, daughter of Jui Pin (John) Lin
David Tang   Chief Executive Officer
Schedule of Due to Related Parties Balances The Company’s due to related parties balances are as follows:
   December 31,
2023
   September 30,
2023
 
Hsin-Ta (Darren) Su  $1,496   $707 
David Tang   2,941    14,023 
Total  $4,437   $14,730 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Details)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
$ / shares
Sep. 30, 2022
$ / shares
Summary of Significant Accounting Policies [Abstract]      
Exchange rate     $ 0.697
Average exchange rates   $ 0.7214  
Number of segments 1    
Tax benefit, percentage 50.00%    
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Going Concern (Details) - USD ($)
12 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Going Concern [Abstract]    
Accumulated deficit $ (10,503,191) $ (10,601,201)
Private placement $ 362,000  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equipment (Details) - USD ($)
Dec. 31, 2023
Sep. 30, 2023
Equipment [Abstract]    
Equipment $ 96,142 $ 67,451
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity (Deficit) (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 24, 2023
Feb. 24, 2023
Jul. 15, 2022
Dec. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Sep. 30, 2023
Stockholders’ Equity (Deficit) [Line Items]              
Common stock, shares authorized 134,213,120 375,000,000   10,000,000,000     10,000,000,000
Common stock, par value   $ 0.001   $ 0.001     $ 0.001
Gross proceeds   $ 375,000          
Offering costs   $ 13,000          
Aggregate amount $ 134,213            
Conversion per share $ 0.001            
Options to purchase share       5,312,500      
Stock based compensation expense       $ 18,750 $ 18,750    
Compensation cost       $ 190,428      
Stock option period       2 years 6 months 14 days      
Stock Options [Member]              
Stockholders’ Equity (Deficit) [Line Items]              
Stock option period       10 years      
Stock price           $ 0.02  
Share-Based Payment Arrangement, Tranche One [Member]              
Stockholders’ Equity (Deficit) [Line Items]              
Options to purchase share       15,000,000      
Vesting [Member]              
Stockholders’ Equity (Deficit) [Line Items]              
Vesting right percentage       75.00%      
Vesting [Member] | Stock Options [Member]              
Stockholders’ Equity (Deficit) [Line Items]              
Vesting right percentage       25.00%      
Chief Executive Officer [Member]              
Stockholders’ Equity (Deficit) [Line Items]              
Granted options     15,000,000        
Options per share     $ 0.01        
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity (Deficit) (Details) - Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model
3 Months Ended
Dec. 31, 2023
Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model [Abstract]  
Risk-free interest rate 2.99%
Expected term 6 years 29 days
Expected volatility 379.35%
Expected dividend yield 0.00%
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity (Deficit) (Details) - Schedule of Option Activity
3 Months Ended
Dec. 31, 2023
USD ($)
$ / shares
shares
Schedule of Option Activity [Abstract]  
Number of Underlying Shares, Beginning Outstanding | shares 15,000,000
Weighted average exercise price, Beginning Outstanding | $ / shares $ 0.01
Weighted Average Remaining Contractual Life (years), Beginning Outstanding
Aggregate Intrinsic Value, Beginning Outstanding | $
Number of Underlying Shares, Granted | shares
Weighted average exercise price, Granted | $ / shares
Number of Underlying Shares, Exercised | shares
Weighted average exercise price, Exercised | $ / shares
Number of Underlying Shares, Forfeited or expired | shares
Weighted average exercise price, Forfeited or expired | $ / shares
Number of Underlying Shares, Ending Outstanding | shares 15,000,000
Weighted average exercise price, Ending Outstanding | $ / shares $ 0.01
Weighted Average Remaining Contractual Life (years), Ending Outstanding 8 years 6 months
Aggregate Intrinsic Value, Ending Outstanding | $
Number of Underlying Shares Vested and expected to vest | shares 15,000,000
Weighted average exercise price Vested and expected to vest | $ / shares $ 0.01
Weighted Average Remaining Contractual Life (years) Vested and expected to vest 8 years 6 months
Aggregate Intrinsic Value Vested and expected to vest | $
Number of Underlying Shares, Exercisable | shares 5,312,500
Weighted average exercise price, Exercisable | $ / shares $ 0.01
Weighted Average Remaining Contractual Life (years), Exercisable 8 years 6 months
Aggregate Intrinsic Value, Exercisable | $
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Party Transactions (Details) - Schedule of Related Parties Name and Relationship
3 Months Ended
Dec. 31, 2023
Yi Lung (Oliver) Lin [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Principal shareholder
Jui Pin (John) Lin [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Principal shareholder, Chairman of the Board, President, and Director
Jia Tian (Jeffery) Lin [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Former Chief Executive Officer
Wen-Piao (Jack) Lai [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Director
Shao-Cheng (Will) Wang [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Former Chief Financial Officer
Kuang Ming (James) Tsai [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Director and Chief Financial Officer
Hsin-Ta (Darren) Su [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Director, Treasurer
Hui-Chuan (Sandra) Lin [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Director and Secretary, daughter of Jui Pin (John) Lin
David Tang [Member]  
Related Party Transactions [Line Items]  
Relationship with the Company Chief Executive Officer
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Related Party Transactions (Details) - Schedule of Due to Related Parties Balances - Related Party [Member] - USD ($)
Dec. 31, 2023
Sep. 30, 2023
Related Party Transactions [Line Items]    
Due to related parties balances $ 4,437 $ 14,730
Hsin-Ta (Darren) Su [Member]    
Related Party Transactions [Line Items]    
Due to related parties balances 1,496 707
David Tang [Member]    
Related Party Transactions [Line Items]    
Due to related parties balances $ 2,941 $ 14,023
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2020
Sep. 30, 2021
Income Taxes [Abstract]      
Penalty amount $ 10,000    
Penalty received     $ 25,000
Income taxes return, percentage   25.00%  
Forgiveness of penalty and interest 7,976    
Total amount of penalty and interest $ 32,976    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Commitments and Contingencies (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2021
Sep. 30, 2020
Commitments and Contingencies [Abstract]      
Operating lease cost $ 200    
Penalty imposed   $ 25,000  
Return, percentage     25.00%
EXCEL 41 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

QM$Y_'YRZJ*M$WJ"8\G M,.2...J:_47T#_/5QM,7-^V==6^[D_].;.B\%AN&!Q3%];H_;W7OQ28N> E= M;$M:A4W#_1&3^AAVLM874\^=!Z\HRED8S4OJ\4W#YX="AK_J\H7R*VVQ*I": M/57$(JUDM&W(S8:KM;_OQ3/8>JWF>$#$-SDN(K274#U&PO=V]R:W-H965T M&ULI5MK<]LXLOW.7X'RU)U*JF195IXS>50YCI-U;5X5);MU MZ];] )&0A0E%<@#2LO?7W]/=( C*DF=2]\/N1!+1Z&YTGS[=H%]N:_?#KXUI MU3*?S9Z> M;+2MCEZ_Y.^^N-FK+>OCDZ/^B^^VJMU2U^'4T(X5,:?*6)&C\Y]JVP9:F].:_+ M?]NB7;\Z>GZD"K/27=E^K;?_,,&>)R0OKTO/_Z^V\NR3QTSPXLF(<%<]9;-F(MW^I6OW[IZJUR]#2DT3_85%X-Y6Q%A[)H M'7ZU6->^7LAAJ'JE%O:JLBN;ZZI59WE>=U5KJROUI2YM;HU_>=)B/UIUD@?9 M;T3V_(#L1^IC7;5KKRZJPA3C]2?0,RH[[Y5],[]7X%N33]6CTXF:S^:/[I'W M*!K_B.4]^G\;K_[G;.E;AQCZWWU^D&T>[]^&\NIWW^CW&/$8^C$8_OD_YZ\?WCQ[.O_ZT^OU.+R_>?+M]=GI]]^J;.SL\_?__T M[?+3>_7E\X?+\\N+Q3[-[Y?]Z?.WBVRN?OWE^?ST](7Z^UNI-]I;G\&Q7\CB MJM6<@]_6)CNO-XVN;EGFLQ=>Y36BH_*FH']Y^+O0+3ZL;*6KW.I2>2PVP('6 MJ[6^-FII3*7@R$8[/&,LY#:E M\1G6MFNCOE>6GEG0/IZ"X6QC'$)!/2 EY[,7WQ?J_=G9%_YT^N+AE.Q@D6P) M"?T9(P [A$D*&BI=_($S3C''_,GO;FI]P++;NRH!VI2)&+L.:/KI(J MP %"N_^EH(P,=:;D!V L0@.!4W:%!!W)V WELZKJ(..K:6H'WU:*"H-80_!_?[BXMS/D2+S]MU MC3PYQKE"C.^6WA:6@N7]Q>++AZDZPPGY!!EMU1IW'.(^BU))&L"Q\CJ7R!GR MU)0658NUE),8+)(T.J1!B*'@8E58/H0@N?, *N^EIML6 )TAKR[:T$50 )A,R?G47H)ZE(:FWT M#^1 U(&SR(,*->RQK%UK(,)J1< @N4,Q1,BUB2>'YTWP=FGUTI9L.7^&P7E9 M^\YQ\D$U0A':^= :V84L3,R/1F=[C>9C/J";,]>FZH(VE.IP),ZA8] :%C$ M,YP@N/*V8VP3E,@Y;0L+'SBU.ZMCREA>^PU.H7>HM MW.6QXR7]S*7MO';P8)(Y,35J;$"Y$2(/"I:$6B0&IY$1-6_Q/ZH\3#X$V:-/ M>N,0/YZ\O.CR=?@@Z;:&M3451'(?9[7=T(DX*SLDZ4Z9@-P80K_'QDS@7SR* MDX2S&&#I'^H">E_KDL\KH0CB:?C#;?!>\ M)X?QZHYH]0YE./N7+CM.OQBY=-S1JM03*QQIO?6\Q17,YX@(B7NV.%??0 %R M]7P^.SZ%.H&VT"9*-OEH-(79D,=O(V#X0&LBVR%Y(JDG/).,/8QG&\Z<.@'% M P C>(9@W,C.!4$.DX]K4FBJAETHP_6RM&AB($<.[!A"7/(\#A_Q[/+UK2 E MHSUV^H\1G]BJZ:!%YZ7.R*8$-HD([7LW_I[]^LMO3Y_]]D)] &R5V6F_GA3^ MLZM#;E/BZFMM2VAG.&<0C$B9_+#9MN\S$87NAZ$H&F\U3[>JEY2/43I7:I++ M<1JDWDZ4@?/AC0+!FK<$-H[)EGR:A$)/QHY5)Y$><%."<0SJ9O>J2[)KWBVH M&<\QT17/ "8Y9VKGZB6ADB!8\I (I JC=WWP*/4!YV.R3EB7,.2Z@S9$.8=" M.=W;0PSAF,)" .J>\3-\!:#F;7;3M,4M6XX'8F0Q[T_!!< M@APJP)QKY[@K2.JC)U#=KV8@D[O]Q,! 0A51W.5C^Z9Q]0W71%H((!F"G$JN M"44(W[%Z.%XJ>VN4WV. ]D95!)!(P4L0.K\'JV,_P8>?HIJ50@-/U%Z D[Y- M2F=&?8JI<@[2I&C265O/"8G*3C)1V?>Z8TJDV4!B=MZ+^D;4LA2N1K[_EE)- M"H>!6]#/J\#UJ;)%;0+OM0(7WQ=OY:@./@OZBW ([%3M8ZEP/*FX;Z) MB$&C24:_M<&M#)F!M^S*'W3LW3,1YYT=X)5CN<.N($!K#4JJ'%-.#OEL%-A, M1GO=MP#KV?3I;\]F!-LTG]FMM_,I^BSFG&/*N5<#%&&'(!]KXA\O8>J4JC,IL_FIX\/B6(NUX6DB/L?H,4]V(^X"3>%V2[;@)F+MLY_( Z) M"(6#8=1J.1\36Y&L U7;41 G-HP: N=.TS'*03)P=*"ZU(X8JZ:B[*5;(L3? M-'451@> K&[3R>92->AG9]8TM$51(1))\.;W6% 8((9MIZ-LSE!?Z[1?E*!C M*L?R@4A5&![<3=Q#0;WWV?9N6(X"(NF08O:E/:X$Q>#(*$DZ&&R"8&YD^"5> M7 FN#3HDXMA5C"8[,X;L<%D8H\,PMYFJ-Z$_SA;FZBZ7E">E^O.0">>) ^8G MI^J3:;/+"GL:]> #E'JHOL#OBS4Y=\3-=9GST:,D&&D>*%V0RYJ[FCM3N8&F MSI\.'/5"NPJ6R5K>9=KS41HAYG<$>XZQCIK4)='L:UOT&!/U"+W4ED?RICCN M<[;J.+6X0]X@[40FW :2V^FA,TMMM!+. M20<8W$%YFC(BK"]"QP<*1F%,'M!$BXYPS"J_Y6"2^:N M/0336)L@&>9U@AT1PW>5"G0V#7C6H]YOPU^.O4(M.GY#@GSR=JI&^\TN@///[44Y XQ]L9%(4J'F9FGKU[1U50TMP@N!G& M8VG@$3R0<:M=PNIVS6AH4-YX;*)O#HX7 X% 7_"?T<2? M&@]>2+$&\ZE,>M3:UMEEUW++!1V6 .@ ,][;;)F;<(URS\2T;Y!X MI(&3(J^P]^7G4$XA@RL*KR"UI:7A3#)*7$H+!) )LM:.]Q*>4JE#>)-/8)WRR%/?3 M[(RC/C1_-+UA1A&D,T'E-AQ8:/:"VCXC B^4B DZH!&F-JJT/PAA&>>IU65O M(9MU279,#XPG>59+M8S<4YDKN08SUS0O(OY#X\;"4/-MB>W0%TQG]0#[CF>< M<"??7^Q1>FOQ>Z)C%G64JZZH($RA)=Y+?O1*3LA>NEKDG3?(.?Z2.04/!"8H M))*2MVR'1^_B*/.I?#!G%4@(G+\G^&A;,Z*VN?:2?2'+&U>O;!N'6%S4NN'& MA3*X ]FYE60Z#LG47S9.V \4M,Z:R"'9'0$L>*K>6*[^746MUR3KK[7HN0:] M)3N;[NU;* M&AJ:^@\PEZ9M&(VW_8!HUV)R& 6,P&5XDE0I]3:,G':8J1_7S[VYGRT-[Q[8 M O29JG_S])M#9+B=^2M7C,?;:^UC9%$E1AR0;.7KSN6A81J9GPU3R@?V81\C MU!X[K\LQ:O028G(3(/BA\-,&R MJ/A<@(+"^\)MPEL\L-.>.!W"4B3/[KB M2EX?L/>@8NA:LD$&H=.2TL#3!E3B*%O,C>:FAAY!5\8:=9#BI<"PJ'),*QW+9Q7;SO(*(OZ?YPCA(+?TL[X%4,KUC>*,1>BC$ M/B;9X#7^"BW<%9C4J$2DHLE+A@L)=U@:5(THOQ-0?C+[+W&97=TK;P,UVSAHD.*F]B7D,:/+.B>F!)]SKA;DQEW(> M-5@'H*>6BY..&6=P#H(6YOH^RZ$F.!&>004PC%8%C?GK9GB-HC);[O VQK'P M$OD1ADWAOC%Y$6:7/5*2.<-OF*34(<4^F?W([-0&]N58F;&8_S&T:E1:@QC^/'M;E[B<,DH M+V]?<%16='CHO)F")9K4/ZDKO0+%V$9?A\8F=.Q9W[&GI3_6A609EZWPCF9@ M9(?GF_R!!PN!_]'N],8>CP;3_H/]!?9W^CO^[W(H0K MY26#);TX*_,3J=EA(-+SR5@TPC4A+>WME,NZE/YG/601$Z57RWH'_-1((")U M[9)WQT8S2#DEREH9>I#7AKH1[[6-*>D*BMXK2+4>7T=(KSIH/M537G4\>SI!."[;. O@#XS YW7%W"%<.'UFQWZ6&TCU M8-$M6QXK/'XV.Y[/'C+$O04J73,K%@SXARD(ZECV_ 4$\MNC#"<7T*P=?/QY M6_$;$(C(0?3STR?'CV?A54/@"5:4W/8DIE&:B:9,[++TY0%^MR+=5-^S;^@: M<$0TU2-H-S+2+,W-@4M+/DEYN6&M:1.8#_:6\ULY2_08,M;C:X^X1SSB8=(5 MMI5I9=+&)6/.P>!-75"XD-WY8+?L9,?&9^D#C>MQBR=14_6!WL+IN>_=#7IM M*+#)=RM#LS_"K:*0U\/ZZ%@9;IU\*/#)C&[ W"S.Y]8T+LK#J83IH%S/<=3U M2$NOD4W3D[WK>7G#2THVLZ[P3E/=JT#*!6LH>1Z+FO?ZLP,]6O5O MJOH<OKKNDW'0$L1*VA"]0DH.Y?;T27C%=-\;YR?) MWP\01>._DN W\JI6_I0@?AO_$.-,_OY@>%S^BN.C)H8';FI66#J;/GMRI)S\ M981\ +SQ7R, (]IZP_]<&XUSI0?P^ZJ& \('VB#^>&UL MC57+;MLZ$-W[*P9JT95A/9RDN8EM('%STR[R0-+;+HHN*'%D\88B59*RX[_O MD)*5!'"-;B2^SIDSP^',;*/-DZT0'3S74MEY5#G7G,6Q+2JLF9WH!A7ME-K4 MS-'4K&+;&&0\@&H99TER$M=,J&@Q"VOW9C'3K9-"X;T!V]8U,]M+E'HSC])H MM_ @5I7S"_%BUK 5/J+[K[DW-(L'%BYJ5%9H!0;+>721GET>^?/AP#>!&_MJ M#-Z37.LG/_G"YU'B!:'$PGD&1K\U+E%*3T0R?O63 IJH;H_ M>^[C\ IPFOP!D/6 +.CN# 65GYACBYG1&S#^-+'Y07 UH$F<4/Y2'IVA74$X MM[C60JU@J56!1LUB1Y1^(RYZ^&4'S_X G\*-5JZR<*4X\K?XF*0,>K*=GLOL M(.$G+"8P3<>0)=GT -]T\&\:^*9_XQ_\N,BM,Y0)/_>YVC$=[6?RK^/,-JS M>43I;]&L,5I\>)>>).<'=!X-.H\.L2^N[[[<7L/R[G9Y]7"[3]QA^.W=UZO1 M%#Z\.\W2]!S>L,&%'>D2*+)8YVB&Z )3'!ZQ%<$"<[]-D?)*DXRQ) YN?'R?3G=Q.X*L> M<8*_80]R/YY;*)BMH)0^9/BK%0;IV3M+QM<(.:*"Q@BJ&4)NH:9"Y2JCVU5% MJ[I Y)90!9(=#J71-5@FT7IY@C@*7=?T^NDA%4^DHJ*;&WFIFG08*"D7M"$" M)BQ29:+T8,H))H'K-G? R6S7$CAMN TF2"(:A$8+<,J9%S195QOT4^M MEH*' )9",560D1%9<[VO7(/2#H0J9,N)BF+/^/]4 +IM,D/ERM>RH*;1UHI< M(I2M:PT"EB5MD=,J;%,\]!K-3J/WMY",('1S+%1#B@[-D2"T.9*B.RHH;JYB MCBK,UM\?E392]"8AO,@)C@\PF?J8Q;M!&Z8HG83 M# G*C]88&E)F6<2GX!?GPD,H"1A=6AH%UT=?SG>=<,;9E9"69!8$C29?*3^8;H.TTV<;D)5S[6C'A&&%35E M-/X [9=:N]W$&QC:_.(W4$L#!!0 ( &%L5%BJ^)JL?@( &T% 9 M>&PO=V]R:W-H965T&,VB/=,#M]8;]J^^=>YD+BU=:_9(9Y:/@/( ,%V*EZ%ZOOV'3SZGC M2[6R_@GKNC;F$].5)5TT8(X+6=9O\=;,80MP'GT"B!M ['77!WF5UX)$,C1Z M#<95,YM;^%8]FL7)TGV4!S*\*QE'R?1E)2L>,@U#8CJ7#-,&.JFA\2?0'MSJ MDG(+TS+#[%]\R#):+?%&RR3>2WB-Z0GTNAV(H[BWAZ_7]M;S?+W_]0:_QW-+ MAO^ /[O:K%GZNUF<*RYL)5(?7^<'O3A^/ \[G8OH66"L3W0"^!I8C%'TTX41)G! U;4I*,F M33G"E2XJ4;Y#+C+ =FS,Z)8!JY)J-[39]BX9UQ;Z**\OHELOQX+"!4.CD[/3 M $QM[CH@77E#S36Q/?TRY_L0C2O@_876M G< >T-F_P%4$L#!!0 ( &%L M5%@JL:K+A@8 ',/ 9 >&PO=V]R:W-H965TRW?NY/%*Z5N3(UJX*XO*G QR:^NCTGV.A M5B>#>-!M?)*+W/+&Z/2X%@N\1ONY_JCI:]1+R62)E9&J HWSD\%9?'2^S_2. MX#>)*[.U!K9DIM0M?[S+3@81 \("4\L2!/TL\0*+@@41C"^MS$&ODAFWUYWT M-\YVLF4F#%ZHXG>9V?QD<#B #.>B*>PGM7J+K3T3EI>JPKC_L/*T^\D TL98 M5;;,A*"4E?\5=ZT?MA@.HV\P)"U#XG![10[EI;#B]%BK%6BF)FF\<*8Z;@(G M*P[*M=5T*HG/GEY;E=[FJLA0FQ^>'";QP6N8?FFD7538W,*TRS.[SCPAA#S/I8)XGCPJ\Q'0(XSB$)$K&C\@; M]V:/G;SQ_S ;_CR;&:LI;_[:Y0&O8'^W JZE(U.+%$\&5"P&]1('IS\\B5]& MKQ^!O]_#WW],^NGUS=7%SV^O?KF A75? &9[JA/@/)OD\;TI C=&!3565-:@FH@%K+I; (=4$! M(SB6E,U1RVH!HLK 4)[ ^&"R U'J$1E&!,*V2*!'$@;4-V&AE3&D1:6(F>-[ MVHES"L@IC=8$I5>;*F,]83QF.F?1>Z'3_!OF.,]E$(_WPX18XN2;*-G-)'NF MA&:%D$E-'5)I$[)ZF2*O&!5W?+*CVV1&C;58!ZR71-)<,"Z,D%$,Z)3V2[+% MX1*+A<8%.U64JG$>95L<.G:4EU$M2;!K[TS))%_Y;^B#'5S5K,BP%WYJBC7$ M$^>$I'7"]"J$2[&4&=R(:A'"BO)JH47%X8TW<5.M%,):-^1+ZN:=E]K8W5-] MYIQ'K0?+&>UV[839 MBYY1S"T!9M?,I3:6.8HEPO,X>0&E[\QD&99UH=8NWQFL.R#?]D),&U0*.X]W MAPB7O6[H=1^0[H $,FV7=BIJM:BX M$X?NVD+65AO[]G; M\Z/K8RPCV"@D0:CD43/8XQZ0>L^(M%]LO@MJIF4^CMG M:K&^WZ V>#S8/0_J7A_!.U[[1A ?A@<37T7M.B0DID9WC6/IJUQ2.V3?4?\L M&O9MVWP66%&H"LI,!TI]2!J[S)S[C66?CBSC \G^C%E?-41 MMMA>3ZQ#FQ1L.#R0"T?^+Y#ZMJ]ZR:*4N/-+?,Z56,F@GH?*Z4[3Y80?_. M/OT74$L#!!0 ( &%L5%@(EM5*Q0, L( 9 >&PO=V]R:W-H965T M&7)F!FNE'TQ&9.&IR*49^IFU MY7D8FCBC LV)*DGRGU3I BTO]2HTI29,:E"1AYU6ZS0L4$A_-*CW9GHT4)7- MA:29!E,5!>KG2\K5>NBW_>W&7*PRZS;"T:#$%2W(_EG.-*_"'4LB"I)&* F: MTJ$_;I]?]IQ];?"7H+79FX/S9*G4@UO\2(9^RPFBG&+K&)"'1YI0GCLBEO%[ MP^GOCG3 _?F6_5OM._NR1$,3E=^+Q&9#_\R'A%*L>+XXM5;NHO MK!O;+AO'E;&JV(!902%D,^+3)@Y[@+/6.X#.!M"I=3<'U2JG:'$TT&H-VEDS MFYO4KM9H%B>DNY2%U?Q7,,Z.YI2CI01FJ.TS1!JEP3I>9A!:YG=68;SANFRX M.N]P=>%&29L9N)()):_Q(>O:B>MLQ5UV#A).*3Z!;CN 3JO3/<#7W3G;K?FZ M_]M9^'N\-%;SZI^W_&YH>V_3NKPY-R7&-/0Y,0SI1_)'GSZT3UL7!T3W=J)[ MA]A'\ZOK<70UA=EX'OV":#Z^78PGT8^[V\5;2@]SW=Y%5]XI?/IPUFFW+^!] M:MB$RG.A$F2\6RS(4RGG81/"LMEO[%P$,U%Z:V$SL!G!1!4ERF?OEX#K2JZ\ MSWY>DWY34AD]2Q^ M2_E'Q4;>C6!+)BW('$%D]FAKV>^!OQLACR/T/D]1:^( +:H=,."G3&@J[>PJ MP+D!;XJ/(O$BY]P[@8)I M19Y5L)]:[EU$&7F;5U"_MOZ%@:0B8-/_/J$EYNPL3_B. 0VD*N=68LICO]5OI$,MO1-\[;6AW0NXBGB1LAS6 MC] +>MV^P_2"?K=5Z]T7]OQ:5B4-.ZZ)WYF0'"\R]CC51'4\G5_<8!)NES(Y M>2OEP[T"S4]D5;""E5/*T-9)_XL/ MNFD]S<*JLB[W2V6Y>=33C+LU:6? _U.E[';A#MCU_]&_4$L#!!0 ( &%L M5%B'N27[3@8 -0- 9 >&PO=V]R:W-H965T;8R]JLKB+QXJDKMSON%]_7;T%X879S5!3.9&_.57V[S\W["!E%)F6<$B7^/-*6R9""8\:W%['8/^ M/G 'E[ET-#7E7RKWQ7G_35_DM)!-Z>_-ZC=J^1PS7F9*%W[%*NY-C_HB:YPW M52L,"RJEXW_YU/IA1^!-\@.!M!5(@]U14;#R6GIY<6;-2EC>#31^"%2#-(Q3 MFH,R\Q9?%>3\Q:W.3$7B03Z1.QMY(/+Z*&NEKZ)T^@/IB;@SVA=.W.B<\GWY M$2SIS$DWYERE+P)>4S84D_% I$DZ>0%OTM&;!+S)_Z G_KF<.V^1!_\^QS0" M'3T/Q+7QUM4RH_,^DM^1?:3^Q<^OQB?)NQ?,/.K,/'H)_>+VX_33W8UXN/S[ M9O:<;2]+?_ST<-,[%3^_>I..Q^_$+IAX**@W-54M]5H4T@EMO%B2)BL]Y8)7 M+3V2;D@LK*G"@C.-S4@H+7Q!XHM6O'/F(>#P/0=,+C*CG2E5'E T>D=IG!/H M$4*699!;D[1..*4#5$8U%V$/H&DR3H;B3FK4/*K;BSF5"C8X\>'F9BIR0]'* M0CY2L.?+<#9D" ZDET^B5'*N2N77(F]H*'XS*TC;@6 >4&V:91$LV-#>1V2T MWG-H Z$\*FL->^"3;XVRH.:-6*B2!'< <7QT.A8DLR*00Z'ZJ.A6>[):EN*^ M=>4,Z:' ^X"_NL>MA],$"3G2; M $SAXZ6Q:_$>[0L_)5EQ@$A*$*O(>94A&K8VB"@\?#CDD'?<&Q=)!.JNF3N5 M*VD5N;=!T^V,ME0E_)><<=W(*XH2X_W,P^_Q&$ ME%Y*:*4?"KVGN6W0Z%DR'834@?1#D'XHI"IYY3EASA(T JKFH KAH\AIU_S6 M;!'-9J .<46P*5>N-B[:P0AA"QY.!HBMJRG,@G(=@;=4.A6A6'IS0D8I'2=' MF\L,$M"@ B7P&'7\+G5+-9T,NX3H;1)B:G)D0Y<)TRX39NUP.DDF;P[DX2;Q MF%\\%@# ^%+4UCPK8L?I%9= .V!4X-L@218KT M?CU.!DF2]'A'J)]M.87XLPKD-?K1 HX+YJ&T!7<7%H_F=A5KR3=6BP,LE4W. M;J$G'X\)#K5EMP4?=U @'A=DJ?@"IEE#7? /2]L_!,"^EU@AN(R@W.#-C@) MQ2QL4Y)#6G=$N7?(NB[7O.,[FJM"X7V?9^]_\8PINM&Q4FBO"!'K40!:%00I MRZR9,)<\BT(1 \/^8,)XG";#O5'0]=S@?S[6M-&&HQIKN2WOND8^]U:C8DI(?Y@M17K\$V_CVO_ETTI# M4QB6TVT;$*$HVSU['V[0])8QV644>[ 2Q0*!JP:]#MP'71R>X]MK^2;[(X=/ M&=1B2^AO/%HJ<3(L G-<)_,'Y5C:",GHR:/N0-QZ*>'F2QO58@SQKD 5(%Z"'>I8N#N1VX&Q. MG\/GSG6CG9-V1G8# !*!P &0 'AL+W=OO&#EIU$H<-@9RIPL@ 4=;I,"=#M(^5'T8[ &O8N\ZN^LC M]]]G=FT(J0@/?;'WQ\PWW\S.?CL\*/W99$06OA:Y-*,@L[:\#T.39%2@Z:B2 M)._LE"[0\E3O0U-JPM0[%7D81]'[L$ A@_'0KSWI\5!5-A>2GC28JBA0OTXI M5X=1T V."\]BGUFW$(Z')>YI3?93^:1Y%IY04E&0-$))T+0;!9/N_;3O[+W! M7X(.YFP,+I.M4I_=9)&.@L@1HIP2ZQ"0?R\THSQW0$SC2X,9G$(ZQ_/Q$?UW MGSOGLD5#,Y7_+5*;C8*[ %+:897;9W7XDYI\!@XO4;GQ7SC4MGV.F%3&JJ)Q MYGDA9/W'KTT=SASNHI\XQ(U#['G7@3S+![0X'FIU .VL&F\D)Z0YE M;37O"O:SXYDJ"F&YRM8 RA1F2EHA]R0306886@[A#,.D@9O6;S>_\D7_IELC=7< M*?]>2KU&[E]&=K?GWI28T"C@ZV%(OU P?O>F^S[Z<(5W_\2[?PU]/'M<+A>; MY7RU6<-D]0"SQ]5FL?ICOIHMYNM+9*_#K1XW\]8=O'MS%W>['^ J.FPR:G'= M2I2O8$ES%Z*E% 27D#-]$:HR\"*TK3 'M=N)A #WFLA5&82$C\K A&N\DREA&AKNGBGM> ^NE1M=3D!/+A>G 0Z5YVG(P.V$2]GHEU$#N MBL":2ML$C'S ;AUP\;P&493*^**\C0?MR-.5F-M7E^(Y*RX([%#DE2:PBJ/D M!$ZT8-"_C=NPD+5ZLPRVGLE66KI,$>+!+\Z,E4O>/!XD1_K467<859=*>W-@ M8#S:_+ QEWL6[=2=#=9N&XTI.8=I9;C=#!^VX^5X7LJWU>0;P:^&"%;*$MS^ MUKET5\(S?2M([[V*&ZY])6TM=:?5TT,QJ?7QNWG]RBQ1[X4T?#8[=HTZMX, M=*W<]<2JTJOE5EG67C_,^+$C[0QX?Z>8:#-Q 4[/Y_@;4$L#!!0 ( &%L M5%@2+P^.LP( /4% 9 >&PO=V]R:W-H965TA+W&:F3)D62<_GU7,KAT M2F@OMG:U[^FM[+>36NEGDR-:>"V$--,@M[:\"$.3Y%@PTU4E2MK)E"Z8I5"O M0U-J9*D'%2*,>KUW8<&X#.*)S]WI>*(J*[C$.PVF*@JF?\Y1J'H:](-=XIZO M<^L283PIV1J7:!_+.TU1V+*DO$!IN)*@,9L&L_[%?.CJ?<$3Q]KLK<%ULE+J MV06?TFG0 M8-Q[ Q!M 9'7W1SD55XSR^*)5C5H5TUL;N%;]6@2QZ7[*$NK:9<3SL;+:F7P MI4)I8;&AIYF$EFC=9IAL*>8-1?0&Q0!NE+2Y@85,,?T3'Y*<5E.TTS2/CA)> M8]*%0?\,HEXT.,(W:'L<>+[!__8(WV8K8S7]$=\/M=NP#0^S.9=T#+)[HN3PD\#C%[>>'1><< M3D_&4;]_"7\QP@V3Y#=RENWDS !NF*B8Q920:57XNA433"8(S6!)B9W26E7KW&_[1)VC=%$G M4=(HP5.O(>.2D)P),)82S4DU:@1N3$4%3*9D.XN:W$"AS9D%J0YH5TE2:;TK MJ54ETIU^8.D/\I8C=YTI#2DWB5"FTMCA7A7\4U7WT.<.]ZQ8H%[[@6.(K)*V M<66;;6?:K+'R[_)F(-XPO>;2@,",H+WN^U$ NADR36!5Z8V]4I;&A%_F-)=1 MNP+:SY2RN\ =T$[Z^!=02P,$% @ 86Q46+L@$<15$P <3D !D !X M;"]W;W)K&ULE5M;D]LVLG[GKT!-ZJ3L*HU&DN_Q MI6I\RZ8VV;@\]N[#J?, D= (,44J #GR[*\_7W>#(*BA:/LA\5 B&GWOKQO0 MBT/MOOBM,8WZNBLK__)LVS3[7RXN?+XU.^WG]=Y4^&93NYUN\.BN+_S>&5WP MHEUYL5HL'E_LM*W.7KW@SSZX5R_JMBEM93XXY=O=3KO;UZ:L#R_/EF?=!Q_M M];:A#RY>O=CK:W-EFL_[#PY/%Y%*87>F\K:NE#.;EV>7RU]>+Q_3 G[CW]8< M?/*W(E'6=?V%'GXK7IXMB"-3FKPA$AK_W)@WIBR)$OCX.Q ]BWO2PO3OCOI[ M%A["K+4W;^KR/[9HMB_/GIZIPFQT6S8?Z\,_3!#H$='+Z]+S_]5!WGWT\$SE MK6_J75@,#G:VDG_UUZ"(9,'3Q8D%J[!@Q7S+1LSE6]WH5R][#^R\N&FQ' MBR[R0/JUD%Z=(/U _5%7S=:K=U5ABN'Z"[ 9>5UUO+Y>31)\:_*Y>K"KGWCX$+_-Z8'V>;A M^#845[_XO<[-RS,$CC?NQIR]^OFGY>/%\PDA'D8A'DY1?_5:>^M)A ]$NVHT M.?L8D]]!)CLBHSYM3?:FWNUU=?OS3T]7RR?/OZ5!Z+#0*W\6JK;XQ:&U,I2+[7#N]9BL2\=@7>-G#V9JNN366<+LM;^L;L MB9KN;;!W%G3WI?$9UC9;HSY7EMZYHGU8],N=<;"=ND=,KA;//U^I7R\O/_#3 M\OG].& M5A !V A9AV3/D)\=&\OS"OH6G]BZ\,IOZP.T715"N6XB=0M6;55 9Y03CZDV M-6RFS-<]I":E!+*;%@JX-=HI@Z60[8ILM5L;ESU8<% ^9$U[\T/J!9=M6=". M5%5(15CS5UM)UF8'H=V_22@C09TI^04("]> XY1M(4Y'-(Y=^;*J6M#X:/:U M@VXK18E>+1?G_XQ"=_*2OW7BJB#N@_E$_#Z*\?MH,O ^=.Y-5G@3A3P1Q-]) M*SNFQ9'\(U8)JF,=A&#D4/OUW;LW[%(6SX=MC:@]AY>!C&_7WA:67/?7=U9<+"CZ.%'T]:Y;-GV[Y# MIMA1QAJSZR2%\0H"LEE*EDTL:59,'G3P8U:GEPCKV>968B_D4D36WZW%YDG& M(GWM]!>DBL@#)QL/B+=G4V;-5B-Q;C:4/R7%4*A1@M]%E\+[)KA!:?7:EFP2 M?H8E\K+VK6,-@C5*MK3SJ36R"TF8B!^%SD:%9O\[P9LS-Z9J S>4$:%(.$C+ MN;U?Q'6*LRZ\/F]:+@&23'/.;H6%#IS:N'H'G=0^T=E<3?C8D^AC3R9]#,&> M0YBN$E#XH]C:1GVT_LN8P_T(N6Q(3KWOM(B"#%34BAK9U'OD71B)BSG"\:_. M[ET@PF/2C)#?83N7?1SM$^HK+(+PW$G5HE>T1RD%)2)LOM*&V5J7A"<\GG-C M*%M3YNBX.A@X$'AM"8 W-+"]W@+H$.]A0$]=OR-OF9,\J9VL&F29&(6J;$! MI9$0"V"PI')#9. ?&35!#?XCR,!!*B4YZJ03#A[MR>Y7;;X-#Y*9MI"V)B1# MZN,$:'?D(\[*#DEFI-A$M/;!V!6U3.JV:'0J?3V-KO5TVA>@;MZ<_W@'R6]T M218?KQ?D2:@I(/>'\#Z,I0/N<_#8F?Q^0? 3X M1$\H=1A_EK'E\>Z>_#*9$)7+Z]E:K'D ([_=>(3FRU;\%%ZP7,R*94.!(2VG=J_"7[ M^:=GCY\\>ZY^1PDJLV6WGAC^NZU#5J24IV^T+<&=X6R#($&RR4^+;;M1"*+# M?3'DW<.M5NE6]9K"-%)G.$AT.7X"U=N9,E ^M%$@B/*&TK3C_D*>9@%-DK!# MUHFD1Z(N ;)[=K-)=HEVS;L%-J,=$U[Q#@H,QW+M7+VF?"ZY/WE)"!):T,)#J@/-$LDX:#6D*ZQ;<4)?5@Y[Y:-OCT[;OH9]]%GUVVQ[+T M]2:TX(1;HL9" V@EI7V^>BON=/)=](%PV="FJ;$VC>C-.H)7V%R#"9.])6CE M8L*_^O5M/\V!9 F23Q!XZ\CH7LKO*-8?]H71F^*^"7-A:,,9($ZO6M\!?W T MR^B[)JB5TWI IQX[]9EX M/Z"@+.:/GSU94&FA.>AL"-^Y_H@WK"M( U_&L)CM&:A#SJJGS+_!# I'! M,)Q9&\X9B:Q(*#T0/V(0%NLG@*''2U-&I(-@8.] !:P=]2.:@(.7[IRJTFY? M5V&BA[3:[EK97"H;?>W,E@X_4/BH1: 4[$(4O2(C)>F8L0F<>2\S:='B M)N3-R$-"CE7%V>1H])>=+EW#[-"/4R>S?'*\LIR>JW?#IBMS?1*(3],8;YLZ MPEE'> #&10R!3SR8AK/!^_C-R99CN>HE6TU*]B]#33.T:M2]WZ'V^^H#/.MJ M"_<9E?&;U+(3U(9]H"YS#A64>2.M-*47Y#[-/?Z=PX6^]5@][ON.=]I5\ 19 MR[O,NQZ#3D+R.X0]QV1+0Z0UM70WMNAR8.V0 MIH0FW T L]$R2T]&2EVV?&O+5@)0U%*R6B)/6<)3!-'4OS+_)Q;Q?&3?]+ I M9@I"[!PV#HV)Y-]T!MS+H L@II &6)PLB".C%AYW]7.*5$8KX9_,0X(Z**^E M*!?KBS#_ *RFL*>!LZR^LWW09L:EHR"=(6=R6G%&ZDE5)WMV;T#R-7_W!Y7+R2/$5M<8!MU<$-D@- M7-]&(^\[:65'M,)#)N8).D%OFM:/8Z"#\A9:6:ZI1H>D/;!T(-5"58Y'O+R] M5 *&#/WPNON6G%V.L[H22J>%5%*A[E9R?ZS!QTR%EBD-0.:C'I?AFV/R21OV MY[;+Z1-7UO'Y:PXV8@'%_N2QS_>3RE)2@\P9&T>>$M#!&Z]::SD:2%8ABPI\ M3/NJ>BVC3;/;E_6MH6KB;KB)MR$$ RGTI7(XD (2L?7[RZO724)^LGPZ&XC. MV7F)'!S]+W[5(=IX#'$T50Z@,(S\/1O[#JOH<'*#V&=4$)$&'[2B3#, 7D@A";,0&O2 E(VSZ[;AZ0=,WR-%&,HT!ZH;)QK T;F' M^1H.\2<.HKI9!4\7X4&D%?8*^3J@1M!@(, KB&V9+O"F)!9YF/]^G<2YI'1? MIM)\'D^K&-QE\8B>IAS[?XD80 M1D ED@%8)VQ9BL=Y=LG1&&8<-$AE(!BH$".V/>$S@P:/> MTV30?J%"Q.60IDZL+60979(<\Q,G&'S@1!"$U%.9:[F$86YH=$NPE4XD"D-S M,$L@E3[@KDWWU='Q,0C4R>?5(TP?++Y/>,PBCW+1(C((46B)]Q(?'9,SDI7:R_1 M%Z)\[^J-;>(\F6M_VQ]D4P2WP*BW$DSG(9BZJRXSU@,YK;,F0G]61T@6?#2X MMPS:VHHF#+.LN\9 [^U+7;&RZ9I78Z[CI)3ZTIW,($AID:,QI5NRQ9X@((1O M]U1**0A"2H1SR$VGAL9,&^K;Z>BR3W-IV(;SO::;U1Y+3 HCAY%T&=XD5DI] M"-/?HX;"#^OZ:.QG:\.[!U %?N;J/WQ QB[2'WI_2Q7#$["M]M&S""' #XBV M\G7K\C 7&(B?]0<&]^S]SD=H"N2\+H=9NULY*M ,ZWL"1SH& BA;'RY "7$F MV!'*!EF1I_&))83V2>*#8;(%$N$"%!@><[<9;W'/WMQ75&5H6JV^5("\&7!T MQH5Y1<>/8;.(_$F/R.SQU(<&+A7%@X)Q;.Y<2>Y>:Q'/5KGL9H M0R>U]+7<0JQD2,WIC4ZS0B'V,U- MQ..$)C<>39=XPN6$<(3#I9PG:M8AT5.GS$''2#@H!TX+<7T7Y6 3F COH (8 MSE8%G;C5^_X27V4.W)COC&/B)>(CS%3#I8GD&N8Q>J0@-/9!7.M<&DL&-?&DK%>V0.53"AZZVE"N-&=F M?**V=V0U"HW^1&QX124O85P2RLMM._;*BHQ7Z9(A6,))_8.\T@5F/=2%9QF4K7.D/B.ST&']BCJ*07(<8CJI,UE^\[2[93/5:_0V^ MY?05OH^&KBD-;H:[NJHI0YX>ZGX/R>PDR1/8D9$HH#[BL(MF0C'1#PD6)C2O M:'9%Q4I]WLL,OK]"\3E>JX !^D^[<[83XY'LV^.1N!=EWE)N<*WI]Q\RCA,L M$>9K'&-W7%F":<]_[)BOU3+BFH>U?MNN$QS,,G MB_/5XCZGWK?(EC>,UB4W_<,4E(*9]NHY"/*/(#C-O0-G3:_C/P\57]Z"1_:D MGRX?G3]1Z;$?.H8]X@F[@>585L9?B?M93(U M[P7>U06Y"\F=]W++3G8H?):^L'==/N7)W5S]3E<<.TQ^=X..&W)LTMW&T.B6 M\FE1R&W@SCLVAELZ'X!',F+M:T$6QZM;&J_EP2IAN"NGX^QU706@6\/SU+)W M-2\7>@5*,!H,%T;KC@5B+DA#P7-O>3_+FO?ZNP5LVW2_W_ YTDDX=8E# MZGYY:C:&_ZO[TTX14@/C-@(.R M\K 'GV%D@,-ZV[_+BQ\=GT7MMBW,Z&M9[ MM-TE_+H.-P=0Q!F^K>T&W9G8@!HX/H^)/T^9JS\B!*'AO ESEZ[EC.7Q'+&^OIM%W&5&L /FF/] 8AV<. Y:.)'UY<)+^"(^C(O_7C"]A5 M(S^(BY_&WQ->RJ_H^M?EQXA_:$*>P,QF@Z6+^9-'9\K)[_OD >F-?U.''-'4 M._YS:S3L2B_@^TT-!80'VB#^RO+5_P-02P,$% @ 86Q46*&>,M:6 P MW0@ !D !X;"]W;W)K&ULI59+<]I($+[S*[J4 M1R55#GI@;(R!*HB=W3UD[;(3YY#*89!:TA0CC3(S OSOMV>K.).[M5LXFLC> EWBK0=5$P];A (3=3+_1V!W<\RXT]\&>3 MBF5XC^9S=:MHYWO-PO!A:>2?PP'&C]]9@/5E*N;*;?Y*I M%UA"*# V%H'1SQK?HQ 6B&A\;S&]SJ15W%_OT#\XW\F7)=/X7HHO/#'YU!MY MD&#*:F'NY.9O;/UQ!&,IM/N&32-[?N9!7&LCBU:9&!2\;'[9MHW#GL(H>$(A M:A4BQ[LQY%A>,<-F$R4WH*PTH=F%<]5I$SE>VJ3<&T6WG/3,[-[(>)5+D:#2 MKU^,HO#\$JZ_U]P\PILK3'G,S5MX\XDM!>JW$]^02:OHQRW\HH&/GH ?P$=9 MFES#=9E@\K.^3U0[OM&.[R(Z"GB%<1\&X0E$030X@C?H_!\XO,&?^/]UOM1& M40%].Q2!QL#I80.VJ<:Z8C%./>H:C6J-WNSUB_ LN#Q"_[2C?WH,?79/39K4 M D&F\(%Q!0],U @F1W">P4UEBU_#0K!X]8[$)26R/85;1?Z5&>4H07'(M>/& M/^782ZW1M3-*%*Q=[>S*UJ[@VF ";"G7"!NFJ6,,*BID.JRU-6YU?F;7Z$+5 MLBLL.VH+DSO95 IZ2>P%T_24-';&/2H,+):H;''T[KA>O4L5(O"2S*$VH)A! MB/H7%_"J=[VMZ%$@!I8*G/6#$3PB4_K'Q5H*9KBP93 XO^@/AOM:"5_S!,L$ M'CF*! )X=223PRZ3PV=GLDW/W+Y81.%09HZ"'2XZEZXN>%P#VSW%N]2U@6>M M70JUKM3^K=T%87YQ;R))=XMYEBG,*!6]F]IH MP\K$)=+ 36RDU6K1(!R>!$%@/_ 2@GX0@NO.\)*V[:KWEV*E!?WEYH#L]195 MS/4SI>G!3Y%;;(H ;BNNGJGX/Z]^B=(!OT;]X1[ S;]0M6%795*6-L2INZA MH/X^9NN[?<,/DQJ>#,+H9/B$/ARJ;G]OY!2H,C=8-<2R+DTS?;K3;G;/FY'U M0[P9_!^9RKA]*C EU:!_3K6MFF':;(RLW !;2D/CT"US^O^!R@K0?2JEV6VL M@>X?S>P_4$L#!!0 ( &%L5%C/(]DXI0, %0( 9 >&PO=V]R:W-H M965TZDUH"DT85TIY%O8ZG:0999D# M8AI_-9A^:](I[J]WZ%\JW]F7-1J:J>Q>Q#8=^U<^Q)1@F=D[M?U*C3\5P4AE MIOJ%;2U[T?$A*HU5>:/,#'(AZR\^-7'84[AZ2Z'7*/0JWK6ABN4<+4Y&6FU! M.VE&!DY6N,[(G(Y" MRX:<>!@UH-,:M/<&:!]NE;2I@<\RIOBU?L@$6Y:]'_W&S-E;S[L]#?M>P@\.PKH"N38$1C7VN$$/ZD?S)AW?= MR\ZG(Z0'+>G!,?3)D@LR+C,"E<"^ X(,_((Y Y2;UY!?A$1FS^1WD#^7+.3="I9DT)SK"59F M#[:B_9;R5R/DV0J]DSEJ31R@9=DJ!IRWA*;43JX4S*QT[BX93V/M[2L;2XHT M66Z\ <18(_9_.\)+#J7TD] MQ8SC0>90'A\%/UR(JY2\)D4_O+OJ=8>?#,2UY7_F][JQ#)R @ 82E?'T,M<> M-R+*UQPYUXR65-AFUPEV;P7[;_4>NL'@XR5_AYUA'5>HXMH+/@ZZT!T$W,^\ ME;+\YN]A$ SZ0ZG[," ]"@ &0 'AL+W=O$.0024W ZF\'"\AS#5++^%4Q MG3JD%IZVC_0/)G>5RP8+6+#\.XEE-G5N'!1#@K>Y?&#[CU#E,]"\B.7"_**] MG3OH.RC:"LF*2JQ64!!J__&A\N%$H#CM K\2^$\$_G."H!($+Q7T*T'?.&-3 M,3XLL<3AA+,]XGJVHNF&,=.H5?J$ZFU?2ZZ>$J63X=IN-V()6I.4DH1$F$HT MBR*VI9+0%*U83B(" KU=@L0D%^\FKE21M=Z-JBAS&\5_)DJ [AF5F4!W-(:X MJ7?5BNME^\=ES_U.X!*B:Q1X5\CO^4'+>A8OE_OH-7*1R# 'T4):=I/64"I2 M[Q^D1HY!O36!00?_OS4_9ALAN?J&?K;MC0W3;P^CSY6Q*'$$4T<=' +X#ISP MS2MOV'O?9NPE8]?#V]'$W;7X,:C]&'3Z,=L!5P<]@E-?VKZ(>2?G7&,L[*:1R\CW^G4R M-N4+Q6PX,ZR=&78Z\WE;;(#K[U! JJX\V>J*90Q.$O&:.2PZHYS[#EP(UC!D M5!LRZC3D"SZ@#5!(B+Q")?!(>:)>G397+.BVL;V#)[YT!CO7EPO!K"_NR<5: M $]-@2*0.8#M956/UC70S%S]3\;GWGAA2YF_&%M8W6.>$BI0#HE"JG=?O4'< M%BNV(UEIKN\-DZH8,,U,U7? ]03U/&%,'CLZ0%TQAG\ 4$L#!!0 ( &%L M5%C02LX0: ( $(& 9 >&PO=V]R:W-H965TS4=LCV[VL[(0O; M@%JI+\27.6?.F3"3N!;R0>4 &CT6C*NIEVM=3C!6:0X%40-1 C6P]EL"45TW>B_@RM'R7V+:ZU-+?4 MX'3R25"^0PO!4Y <72U!$\K4-;I!]^LENGIY'6-MTMA@G+:4\X8R/$,9A.A6 M<)TK](%GD)T28*.O$QD>1,[#BXQK* ],%/Y$1= MS2+'%_U5S;[/-DI+\W?\T5>JAFG8SV1;=*)*DL+4,SVH0.[!2UZ]",;^^SZ; M_XGLQ/2P,SV\Q)[,TK0J*D8T9+9-:$IUG]^&9.Q([ 39)S>!/_*CX%T0X_VQ MF=[(L1^$_E/DB=)1IW1T4>E*TKV1B4IF:F$&3J_.T1_9H[&9?/XSD1&*&RF5C- M1HO2-?U&:#-"W#(W0QZD#3#W6R'T86,3=)^-Y#=02P,$% @ 86Q46.*, M2OH& @ TP0 !D !X;"]W;W)K&ULK51=;],P M%/TKED%HDT:=C[:#DD3:6B9XF%2M&CP@'MSTMK'FQ)GM-N/?<^VDH8AL\,!+ M[&N?,6;R DIN1JJ&"G>V2I?<8JAWS-0: M^,:32LFB()BRDHN*9HE?6^HL47LK105+3.[P'?!'0F),Y<4[62CVXX/,F MI8%+""3DUBEP' XP!RF=$*;QV&G2_DA'/)T?U6^\=_2RY@;F2GX5&UND]!TE M&]CRO;1WJOD$G9^)T\N5-/Y+FA8;!Y3D>V-5V9$Q@U)4[DOO5@IR]/D^8Q2, U?8_3N6_0102P,$% @ 86Q46'3*(3Q"!P >$D !D M !X;"]W;W)K&ULO9Q=;YM(%(;_RLA=5:W4QC#^ M3)I82LP 76W4J-EV+ZJ]('ALHQIPAW$^5OOCEP%B/ Z9&.W;^B(!S'G.X'G% MF3D'YO0N%=^S)>>2W,>K)#OK+*5Y-_,4Q$',M\5BVZV M%CR8%4;QJDLM:]B-@RCI3$Z+8U=B M^!PMEE(=Z$Y.U\&"7W/Y97TE\KWNEC*+8IYD49H0P>=GG7/[Q.]9RJ XXVO$ M[[*=;:(NY29-OZN=C[.SCJ5:Q%<\E H1Y/]N^92O5HJ4M^-'!>UL?2K#W>U' MNEM=<8?,^#S8K.3G],[GU04-%"],5UGQE]R5YP[Z M'1)N,IG&E7'>@CA*RO_!??5#[!C8SQG0RH >:M"K#'J'&O0K@_Z> 1T\8S"H M# :'>AA6!L-]@^$S!J/*8'2HAW%E,"YZM^R.HB^=0 :34Y'>$:'.SFEJHQ!$ M89UW890H[5Y+D7\;Y79RN&-VP\L1*3_093SURF29RF1&6S/BLP=XS MV]O4 .CFE[V]=OIX[1?42+P,Q!&A_7>$6K37T*"IV=SE-T9SQVS^^V9U1.Q! M84Z;?DZSNY-TSFU_S=6YN/6ON'V[>,_1D;ZOB7L'K_1\5 M?_LCMR(?)8^SOQN:?%&ZZ#>[4#'D)%L'(3_KY$$BX^*6=R:O7]E#ZT.3=) P M!PEC2)B+A'E(F ^":7+L;^78-]$GTS2.\[B<*56^(]DRR%V08".7J8C^:;SW M793 00%4XXW;B=WK4[MG4^NT>[NKK*=G]D8#J_CH9SK&1K:534,#K>U'=^PB M'7M(F'_856B=/MAV^J!%IZ\#06Z#U88W=;81U/9.4\)&.Y=D'5F6O:<%I$MV MD$L7Z=)#POR7VJ_U_W#;_T-C_WLBS3*R%FG(^2QKZG:C?=MN+V'#)[>!O7Y' M^F1(F(N$>4B8#X)I*AIM530RJNC3?,Y%E"Q(F&:R445&^[8J&CU1D=U[*B*D M2X:$N4B8AX3Y()@FHO%61&.CB,X7"\$7@>0DB---(IMD-&[H>37@V!MM&!VU M'<B/"99#QYQ5E9K6-E^2B: M+KLZX6R;,\ZE[!Z'6-\N>7S#16.5PPQJK3PDS8'2&)3F0FD>E.:C:+KXZL2W M/?CYU3<;FA2'TAPHC4%I+I3F06D^BJ;KLD[(V^:,_*&Q&)J7A](<*(V]\'O9 M5AF,&V4&3==#:3Z*ILNLSMC;YI1]*;.UB,+FB28T80^E.5 :@])<*,VK:"I1 ML9NDI/K,QD_8)2'3&A/H30'2F-0 MF@NE>5":CZ+ISW#6=04*K"N866WU!Z4Y4!JC3^L*=N-C8B[4KP>E^2B:KJVZ ML$#-A86O/)/J80Q3J#4C6DL*6DB TAB4YD)I'I3FHVBZ[.JR!*4_/]12:-D" M2G.@- :EN5":!Z7Y*)JNR[JX0E.:C:+HNZWH&->?G6X5? M:%$#2G.@-%;1]/!+GX1?:/T"2O-1-%U6=?V"FNL7TV7$YX3=\W"CWB,GG^;Y M+8X+<]2%%C6@- =*8U":"Z5Y4)J/HNDRK&L?=/P+HBZT[@&E.5 :@])<*,V# MTGP43==E7?>@YI<@/!$DDL^JYP@:7\DR$UJK#EK5J&@OYX$9U*\+I7E0FH^B MZ6L5U!6+WF$5"^,[-69&6TU!:4Y%VR^F[[WPPZ!.72C-@])\%*T45'=G.9>8 MBT6QM$]&0O4J7[FZR?;H=OF@\V+1G+WCS#YQRT6 :DRY)M%E(!91+L$5G^=( ME:[JE-.*QQV9KHM%8VY2*=.XV%SR((_-ZH3\^WF:RL<=Y6"[V-+D/U!+ P04 M " !A;%18RU\,NK0" "X!@ &0 'AL+W=OJAS4[F)47ENR. M[?C?=Q\-^\-N\-DJ_3*9(@$K[DLS-3+B,I+WS=)ACDS/55B M87=2I7-&=JJ7OBDU,EZ!!3+C-R"'T]*ML0GI&_E7-N9W[)PD6-AA"I 8SKUKON7LY&+KP*> M!6[-P1BX 2AQ(0< [.O#=Z@E([(RGAI.+TVI0,>CO?L]Y5W MZV7!#-XH^5UPRJ;>A0<<4[:6]*BVG['Q,W!\B9*F>L*VB0T\2-:&5-Z K8)< M%/6;O39U. #TAV\ P@805KKK1)7*6T8LGFBU!>VB+9L;5%8KM!4G"O=1GDC; M76%Q%#^12E:9DARU.?EP$?9'5W#WLA:T@X^WF(I$T*D;$1/2G,(9/-ECP=<2 M0:5PSX2&9R;7")0A5%SPM73E-C"3+%F=V7 ET32K,->6L5C"@^(H)SY9!TZ' MGS1J9[7:\ VUD046E!FX*SCR/_&^==[:#_?V9^%1PEM,>A#U/T$8A-$1OJ@M M9U3Q16^5\_]5!WY<+PQI>VQ_=A6JUG'>K<-=Y4M3L@2GGKVK!O4&O?CD0W\8 M7!UQ>=ZZ/#_&'C\*LSI+-2*(@M#R$VA&V"6S)NK7Q\]UB$T<]()P/)[XFPX% M@U;!X*B"N]?27FOD8-/G77F/PX>P0Z8-A&/@;&>.E&38"AJ^3]!&249"V@O4 M)6OX;SFBWF@<#;K+,6JSC]Z7G8N-X%APV F4O$M!330^_!Y_Y?8/NDF.>EGU M3 .)6A=4-Y9VM6W+UW4W^AU>]_0'II?"GG:)J84&O9']++KND_6$5%GUIH4B MV^FJ869_+:A=@-U/E:+]Q"5H?U;Q+U!+ P04 " !A;%18V/ ?2CD$ "% M% &0 'AL+W=O+Y$F*^&7O8>QFX8\N5 M,@/^9)31)W0O?\RDO$$D@EXRD2L!A[4WQQ2?K&P#[QP& CM]K(I#+G M_-%T/D=C+S"(((90&1=47]9P!7%L/&D M?V>16HV]H84"5F (8^E_4>;\MG 0V$N%4]*8XT@86EQI4]E M(;8,3G<9D-* 6-Q%((ORFBHZ&0F^0<(\K;V9ADW56FMP+#6S,E-"WV7:3DUF MBH>/*QY'(.2'=T."SSZAFQ\Y4\_HZ!H6+&3JV+049;$\1K^AF>9%E,> ^ )] MRVQEIZ:RVF+D*XW(^/7#,OIE$9WLB-Y#7WFJ5A+=I!%$K^U]G4F5#GE)YY(X M'5Y#>()Z^",B >FA^]DU.GI_C-XC'\D5%2#+BR-2KRIA$/T0./<5?HF^,XH[>$/*_C#[C3_0]#4 MS)>+V$[W[7&?5[C/#^-]C=W-=&>8]OAQ4,M)T+WR-V4V[MJ[(W0 OZ6%^+#R M;R?@G@!WI Y)D#H)TGT&])O, IA)D0N=7<;$OLEP!NN01ZVOV"F$^R=C1RY[ MYJ6#^CKSJ947'R"]-\4N^E;=Q6V%%]?*BP^4WD:H>XK>2GAQK;SX?Y#>_^)O MA.R./$36'1J@Q+[ NAA2:R[N++K-16\$_HLE%]>:BSN++GH :3F51F:EZB\R MW5$NM#*]5DKA5LMN67@-OQ.H.V8;2M8P2MXRZ]O+796Y$['3>@L/^ MULE0 F)IS[\D"GF>JN*0J!JMSMBFQ5"OWA)U$,"VT:G)QIC*(X M\RHZBF?VG&G.E>*);:Z ZH5@'M#W%YRKEXX)4)T\3GX"4$L#!!0 ( &%L M5%CK>/5+3P0 *$6 9 >&PO=V]R:W-H965T4.G5;W84@FC45B]VR'PG]_X[1- MB@[<;46^M'&2>7DS>?$;NS]3^M%DB)8]%[DT@R"S=GH6AB;.L "SKZ8HZ4JJ M= &6AGH2FJE&2*J@(@]YMWL4%B!D,.Q7YT9ZV%>ES87$D6:F+ K0+^>8J]D@ MB(+EB5LQR:P[$0[[4YC@&.V?TY&F45BC)*) :8223&,Z"#Y%9^?\U 54=_PE M<&96CIE+Y4&I1S?XF@R"KF.$.<;600#]/>$%YKE#(A[_+D"#^IDN0"#%RJ_%XG-!L%)P!),H/ZAB>0D6AGVM9DR[NPG-'52I5M%$3DCW M5L96TU5!<79XBSE83-@(M'UA=QJD@:I>ANU,#F?,^'O,.FQ&R5M9MAGF6#R.CZDK.K4 M^#*U<^X%O,1XG_6B#N-=WO/@]>I2]2J\@W?P_A;L6RDG;.=[3D+2N^R;D.S' M#18/J/]Y*U\OG/OU"3/:C0>YN_UQ_$ M&]E7BX5YD_9!"[0/:]J'WAJO2HB^!)LQFR&[4,44Y,M;9/UP(RUD+*:0,Y.! MQDSE"6H/S:.:YI$7][H4;$1O?^=:97*]$+Q@6U;TN*9ZW)80CEN@?5+3/OE8 M(?CAWA1"AUUD(&AJEVY:<_CG"G3282/*1R0H;:>:URZ%)@]1/N&RAVY9\%L@?S'S%V**/5= :/-<$H";)"$S9 MYV>,2]=/L.]I*F+OI!+QAC+W/N(>Y=Y(@")U0/Q(T@#AE88?;ML*-WX8]5K3 M1AO>F&'E-; MM^/%^8H:(&@N,_*8USD#M763H6HU[D>>[[![HV"L$+^*V MY6S<,#IJ30AM>&/4F&/D-;$MA.#'>S5)?!$2R'7(='YBDFB,,?);V>^E4\.- M$'^_5K#'&6*,%_=)A"923S)+?T/+E_TM27RJ-07*_H5W"DTC8 MW;H&Q(^R;<$;3^0GK4FE#6ODC35R_X)PWSS=L;T!-!QJJ470[< ^I=Z>%_4$L#!!0 ( &%L5%AA2^[MR@( )P* M 9 >&PO=V]R:W-H965T'J@\FN8!5)\YL!]I_/]M)(U+2:)6R%[#C>P[GGIR$ M.]DS_B2V !(]IS034VLK97YAVR+>0HK%.M8*"Z$9&D%5@I2DI7?^+GRX0#@!N\ O K@ M_2O KP"^:;149MJ:8XFC"6=[Q'6U8M,+XXU!JVY(IN_B4G)U2A1.1K= L80$ M+3"7+^B.XTQ@8[! )W.0F%!QBL[04J4G*2@@MD;S I!DZ!!)0*!+3'$6J\49 M:I(^W$"Z OZH#NZ7;5KGN'S/^[:PT]5BZXEI.*QK<^2.&@GUL_LA16#516#MMY+PJ$AU*^7 M710$?CBQ=X<]'1>Y0>@[=55#;%"+#3K%7@F2G=UAE6G,.62G:%G4N6Q3VLGV MT;O4$UFC\4'=^.!_)770IP<]D34\&-8>#/M.:DDX:(1P/'R3U..BT G;B)K]#NJ^QW]KWB.^O2@)[*&!^/:@W'?\1P? MO2.]<>"^B>=QD1N8O[]&0.V#V4'/;3>8;XBRG\):X9SS4.6;E[-0N9$L-^/$ MBDDUG)CE5HV/P'6!.E\S)E\W>D*I!]+H+U!+ P04 " !A;%18$6X4B/L" M !<"P &0 'AL+W=OBKG FEV[Q&D.3*:<$0&KJ775OPPGNK_I\#.%G6R4B8YDR?FCKMS$ M4\O1$X(,(J4=*#ZV< U9IHUP&G\K3ZL>4@N;Y;W[=Q,[QK*D$JYY]BN-53*U M)A:)844WF;KCNQ]0Q3/4?A'/I/DGN[*O-[9(M)&*YY489Y"GK'S2IXI#0X ^ M[0*W$K@O!:,W!%XE\%X*!F\(!I5@8,B4H1@.(54T\ 7?$:%[HYLN&)A&C>&G M3"_[0@E\FZ).!3_H$DIR%H&B:R<_D"WE8A.3LXV??5CB*[FM'E>.L M='3?0;BR%NT5]WZ_MNAX&-X=4QNOL89VZG8PA1CWC]<^(ZKM&!+$%JS@TX?^R/G:!NF49N&)S X #FJ @R[W8 Z,9NJ9T)QOF&KC M5NI'1J_OS6W0=_#GV]LFD,Y1C@5R(K,#(,,:R/!=0 1$@)=PVYF==3H- MN,87X]&+@]4Y\K';XT1F!Y F-:1))Z1[KFA6W3/'4)J\VM*>^QI3Y]C'8CJ1 M68G);N0C.8BUR>LDB32',C6I6^O4\>4MQGS%),EBAU.F-<>^( M,IJ$.O@'4$L#!!0 ( &%L M5%B5!TH9O@( $ ) 9 >&PO=V]R:W-H965T(3DLZ:;0MV+W&9I\0L/+1*'L+]G58T//(=E&:5$V8IQ!R7C] MI ^-#P<"Y'0+_$;@'PNB9P1!(PB.!:-G!*-&,++.U*E8'U*J:1)+L2/2C$:: M>;%F6C6FS[A9]KF6^)6A3B=3499,XSIJ12C/R51PS?@*>,9 D;,4-&6%.B=O MR=T\)6>OSV-78U@C=K,FQ*0.X3\3(B W"%TK\HGGD'?HI_WZH=\#<#'?-FE_ MG_3$[R6FD U(,+P@ON<'71/JE\^A0KEGY<,.>?KO#2/O8Y=KIX2E)X(]<734 M.CKJHR=?*Y#4>$@*P#.%9$+I+O=J2F0IYGS=)GC:QN[VT)3>2"\UY42P)Z:$ MK2EAKRDSX+30CX25E5"=^WC2"WCIORG\V]S0.[8W/5'()XY$K2-1KR.WH#>2 M7Q#\MV2X^[!*=IG2RWBI*:>$I37LPX'#WL /6X-K3]R#VE*"7-D:K7!+;+BN M3]RVM[T&7-GJ=]0_Q>M!76QEUY-B9X[)VOWZ^=II^X(LZ'C:Z5#3V/3[G'MLWQ#"HS4JP MNSEC)EJ60M9#,C>F^A#']73.2EI?J(I)BQ1*E]38KI[%=:49S6L@E2+N=3II M7%(NR6@@%^5-:>IHJA;2#$G:AB)_^YP/23=]3R(O-U8Y&Y*'L[<_%LI3=R4GGX?QZ/W[F@',2!T4O#Q"]Z'1P80 Q\?1 \>?54?FK77E'.+52GGJ* MT?J'N7K.$R:=!1S9X1M3T''DN-GST:!0[OH>E&.C4W*IM,OM,_CO23-\#UCWP" 7 MHC78(SXP&E34&*;EC>VXP2[X!(J:]OVJL@YGFJZZO4NR(;B;33)1.F>Z3=,E MZ]!H(%@!=C2?S>%N5!4#:(PJ;2/G=*8D=1[6C*9A9:=,B#MX5K\7.]K+8FO? M.K!KLFU:0TW3R_@.Z&^K>>UMV=Z+=*.*/RKS:6&G(UT?*HW=:E;PI>LOB]8 MIM[%U6E5B=5'P6>R9'[R!R<<#>B:%\V5YK]L-BB5J0TP3:)'I@V?;D=^:EK= MLZ59E].RP#WWCM#SWUWG&9-,4[%MVM;^:U[E%SM.KOZ59?=;9=]PT&/S G[M M)B^/P61Z#":/HB;[QV R>Y4FX^8%OG5*V#DCM-$(SF)#\@U.=F*3-)HLN#!< M-KTYSW,FGQP5K+RA$_O'PHZ^'9^S@BZ$N6_!(=FTO[*<+\JL'74+"]&,VK2_ MP/2Z:7L0M+FXS-F2Y>.FJV<3UXQLPV9M+B#L(S?N"B,8QV-A!# L#^8 XW@6 MEN=_FD\?G8_',&_](-)'.7V4XUDA9.P^6)XP)[-7>*99EB1IBJWH>!QT,,;6 M+4WA)ZR&>0,&E@-V!D67BW ML3S P'8!JQW('\X#-17F) GL*N8->X)Q),LP!&HQ7*-IBJQ."I_P_F!/29)D M61@!+.P@23 $GD8W'L?Q>OW5+SY#]KH-U!+ P04 " !A M;%18EXJ[', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0 M(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I M6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6 MFD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L# M!!0 ( &%L5%A1$(BH"P, (4 / >&PO=V]R:V)O;VLN>&ULQ9A; M3]LP%(#_BI4G)DU+8TJYB"*-RUBE:504\8K."\5!Z:316AHI["2_N3WLHLF?I MY%PJZ3?CK#U7D+%::EG+-ZC&V2!C;F5>OALKWXSV0LU*:Y0:9T77< _6R_*O MZEF O!-SU]9X,;\5"#+.1@,<<"&M\VV/=GR!C,^ G;M2X\TWJ3S82^'AVIIF M+?4R#(.SR*-IM''8'KL@GMA_":-9+&0)EZ9L:M"^BZ,%%0"U6\FURY@6-8RS M;1?V55?L2GL,$IOH;BCL&V:*MYY4W:P]XD8QM"<2&^RD:L'305X878%V4#$\ M0U:+!"L1N[%%J^M1V8P'1TWCBI(8(\ M(B"/TD+.FKH6=L/,@LWD4DN\3(2L69:FP:P901X3D,>)(VE0(^%1EV![J7M MY>Y!6JBKIT:N0Y\8B)1)8IO,O"D?5T958-T#"WCHO+U+P,NE_Q134C8I$NOD M-E3B6IT*BWAW5F@GVHV.BPDIE12)73+1I:F!W8E7Z#%1YBB2JZ.NI0^=7)M" M<"UX7!.@2]F'I,Q1)%;'K)D[>&K"KNOJ.:#&8)0MBL2ZV&8S3")3E$6(V6P6P/OP1B3,H916)ID&;K[;8XI1&> M6",]MX6G[854+D[7G)(*3RR5WY9['XW\+DEL$G*Y]!\PI1.>6"&+#T)C#&)-R#$_L&"KYX L:8U+&X8F-0V+VWTW*.#RQ<>*MSOL+G!(-3RP: M=4X2NMH?J)MW!87PI53BT+AVYO/#P(VEHT2EU@W8W^ M842U_86U_?UV]@M02P,$% @ 86Q46-JP!6U2 0 _A$ !H !X;"]? MLB+:UX9S7&GF=&Y_M@_C/1 MEF53F$];?'>F]W\,UC]VO+K:&*^BPC:AP^B M&&6,!22]8"U :T*N28#7A&"3 +$)R28!9A.B30+4)F2;!+A-"#<)D)N0;A)@ M-R'>)$!O1KU9@-Z,>K, O?GE95N WHQZLP"]&?5F 7HSZLT"]&;4FP7HS:@W M"]";46\6H#>CWOQ.O9V_M\8M/8\U?F"_DVH_W6N6Q\_+QR;BG,PX:_C=<_P% M4$L#!!0 ( &%L5%A6#%%4?P$ ,,2 3 6T-O;G1E;G1?5'EP97-= M+GAM;,V8RT[#,!!%?R7*MFI<&R@/M=T 6^B"'S#)I+'JEVRWM'_/)'U(H!)1 M%8G9Q$H\<^^U1SJ+3-ZV'F*V,=K&:=ZDY!\8BV4#1L;">;"X4[M@9,+7L&!> MEDNY "9&HS$KG4U@TS"U&OEL\@2U7.F4/6_PUU#"*J";"Y#>I$&J]A& MLYBV&F+1+W$BHZMK54+ERI7!EB+Z +**#4 RNMB)#OJ=$]XP[)[\8O].IL\0 M*^?!^8@3"W"^W6$D;??0HQ"$I/J/>'1$Z8O/!^VT*ZA^Z8W7^^'"LIM'9-UR M^1U_G?%1_\P<@DB.*R(YKHGDN"&28TPDQRV1''=$N\ K @ $0 @ &O M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 " !A;%18F5R<(Q & "<)P M$P @ '- 0 >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 M ( &%L5%CD-MSFZ04 ,P? 8 " @0X( !X;"]W;W)K M&PO=V]R:W-H965T&UL4$L! M A0#% @ 86Q46&0P;KJ< @ 5P< !@ ("!,Q, 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 86Q46).W MC@!6!@ K#8 !@ ("!2AX 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0#% @ 86Q46+ _-/B,$@ JC( !@ M ("!TR\ 'AL+W=O&UL4$L! A0#% @ 86Q46*KXFJQ^ @ ;04 M !D ("!C$8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 86Q46(>Y)?M.!@ U T !D M ("!^E, 'AL+W=OG8# !*!P &0 @(%_6@ >&PO=V]R:W-H965T M !X;"]W;W)K&UL4$L! A0# M% @ 86Q46+L@$<15$P <3D !D ("!%F$ 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ 86Q46(G& M/X7C @ /0H !D ("!2WP 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 86Q46'3*(3Q"!P >$D !D M ("!080 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 86Q46.MX]4M/! H18 !D ("! M%9, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 86Q46)4'2AF^ @ 0 D !D ("!SIT 'AL+W=O&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$" M% ,4 " !A;%185@Q15'\! ##$@ $P @ '.J0 6T-O F;G1E;G1?5'EP97-=+GAM;%!+!08 )0 E /H) !^JP ! end XML 42 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 72 156 1 true 21 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://geecenzymes.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://geecenzymes.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://geecenzymes.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://geecenzymes.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals) Sheet http://geecenzymes.com/role/ConsolidatedIncomeStatement_Parentheticals Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals) Statements 5 false false R6.htm 005 - Statement - Condensed Consoildated Statements of Stockholders??? Equity (Deficit) (Unaudited) Sheet http://geecenzymes.com/role/ShareholdersEquityType2or3 Condensed Consoildated Statements of Stockholders??? Equity (Deficit) (Unaudited) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://geecenzymes.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - General Organization and Business Sheet http://geecenzymes.com/role/GeneralOrganizationandBusiness General Organization and Business Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://geecenzymes.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Going Concern Sheet http://geecenzymes.com/role/GoingConcern Going Concern Notes 10 false false R11.htm 010 - Disclosure - Equipment Sheet http://geecenzymes.com/role/Equipment Equipment Notes 11 false false R12.htm 011 - Disclosure - Stockholders??? Equity (Deficit) Sheet http://geecenzymes.com/role/StockholdersEquityDeficit Stockholders??? Equity (Deficit) Notes 12 false false R13.htm 012 - Disclosure - Related Party Transactions Sheet http://geecenzymes.com/role/RelatedPartyTransactions Related Party Transactions Notes 13 false false R14.htm 013 - Disclosure - Income Taxes Sheet http://geecenzymes.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 014 - Disclosure - Commitments and Contingencies Sheet http://geecenzymes.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 15 false false R16.htm 015 - Disclosure - Subsequent Events Sheet http://geecenzymes.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 016 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://geecenzymes.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://geecenzymes.com/role/SummaryofSignificantAccountingPolicies 17 false false R18.htm 017 - Disclosure - Stockholders??? Equity (Deficit) (Tables) Sheet http://geecenzymes.com/role/StockholdersEquityDeficitTables Stockholders??? Equity (Deficit) (Tables) Tables http://geecenzymes.com/role/StockholdersEquityDeficit 18 false false R19.htm 018 - Disclosure - Related Party Transactions (Tables) Sheet http://geecenzymes.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://geecenzymes.com/role/RelatedPartyTransactions 19 false false R20.htm 019 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://geecenzymes.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details 20 false false R21.htm 020 - Disclosure - Going Concern (Details) Sheet http://geecenzymes.com/role/GoingConcernDetails Going Concern (Details) Details http://geecenzymes.com/role/GoingConcern 21 false false R22.htm 021 - Disclosure - Equipment (Details) Sheet http://geecenzymes.com/role/EquipmentDetails Equipment (Details) Details http://geecenzymes.com/role/Equipment 22 false false R23.htm 022 - Disclosure - Stockholders??? Equity (Deficit) (Details) Sheet http://geecenzymes.com/role/StockholdersEquityDeficitDetails Stockholders??? Equity (Deficit) (Details) Details http://geecenzymes.com/role/StockholdersEquityDeficitTables 23 false false R24.htm 023 - Disclosure - Stockholders??? Equity (Deficit) (Details) - Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model Sheet http://geecenzymes.com/role/ScheduleofFairValuetheStockOptionsBlackScholesOptionPricingModelTable Stockholders??? Equity (Deficit) (Details) - Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model Details http://geecenzymes.com/role/StockholdersEquityDeficitTables 24 false false R25.htm 024 - Disclosure - Stockholders??? Equity (Deficit) (Details) - Schedule of Option Activity Sheet http://geecenzymes.com/role/ScheduleofOptionActivityTable Stockholders??? Equity (Deficit) (Details) - Schedule of Option Activity Details http://geecenzymes.com/role/StockholdersEquityDeficitTables 25 false false R26.htm 025 - Disclosure - Related Party Transactions (Details) - Schedule of Related Parties Name and Relationship Sheet http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable Related Party Transactions (Details) - Schedule of Related Parties Name and Relationship Details http://geecenzymes.com/role/RelatedPartyTransactionsTables 26 false false R27.htm 026 - Disclosure - Related Party Transactions (Details) - Schedule of Due to Related Parties Balances Sheet http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable Related Party Transactions (Details) - Schedule of Due to Related Parties Balances Details http://geecenzymes.com/role/RelatedPartyTransactionsTables 27 false false R28.htm 027 - Disclosure - Income Taxes (Details) Sheet http://geecenzymes.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://geecenzymes.com/role/IncomeTaxes 28 false false R29.htm 028 - Disclosure - Commitments and Contingencies (Details) Sheet http://geecenzymes.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://geecenzymes.com/role/CommitmentsandContingencies 29 false false All Reports Book All Reports f10q1223_genufood.htm gfoo-20231231.xsd gfoo-20231231_cal.xml gfoo-20231231_def.xml gfoo-20231231_lab.xml gfoo-20231231_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 48 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "f10q1223_genufood.htm": { "nsprefix": "gfoo", "nsuri": "http://geecenzymes.com/20231231", "dts": { "inline": { "local": [ "f10q1223_genufood.htm" ] }, "schema": { "local": [ "gfoo-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd" ] }, "calculationLink": { "local": [ "gfoo-20231231_cal.xml" ] }, "definitionLink": { "local": [ "gfoo-20231231_def.xml" ] }, "labelLink": { "local": [ "gfoo-20231231_lab.xml" ] }, "presentationLink": { "local": [ "gfoo-20231231_pre.xml" ] } }, "keyStandard": 145, "keyCustom": 11, "axisStandard": 6, "axisCustom": 0, "memberStandard": 8, "memberCustom": 12, "hidden": { "total": 59, "http://fasb.org/us-gaap/2023": 48, "http://xbrl.sec.gov/dei/2023": 11 }, "contextCount": 72, "entityCount": 1, "segmentCount": 21, "elementCount": 226, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 252, "http://xbrl.sec.gov/dei/2023": 30 }, "report": { "R1": { "role": "http://geecenzymes.com/role/DocumentAndEntityInformation", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R2": { "role": "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R3": { "role": "http://geecenzymes.com/role/ConsolidatedBalanceSheet_Parentheticals", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "unique": true } }, "R4": { "role": "http://geecenzymes.com/role/ConsolidatedIncomeStatement", "longName": "003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:GeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:GeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R5": { "role": "http://geecenzymes.com/role/ConsolidatedIncomeStatement_Parentheticals", "longName": "004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals)", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": null, "uniqueAnchor": null }, "R6": { "role": "http://geecenzymes.com/role/ShareholdersEquityType2or3", "longName": "005 - Statement - Condensed Consoildated Statements of Stockholders\u2019 Equity (Deficit) (Unaudited)", "shortName": "Condensed Consoildated Statements of Stockholders\u2019 Equity (Deficit) (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c22", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c22", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R7": { "role": "http://geecenzymes.com/role/ConsolidatedCashFlow", "longName": "006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "unique": true } }, "R8": { "role": "http://geecenzymes.com/role/GeneralOrganizationandBusiness", "longName": "007 - Disclosure - General Organization and Business", "shortName": "General Organization and Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R9": { "role": "http://geecenzymes.com/role/SummaryofSignificantAccountingPolicies", "longName": "008 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R10": { "role": "http://geecenzymes.com/role/GoingConcern", "longName": "009 - Disclosure - Going Concern", "shortName": "Going Concern", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R11": { "role": "http://geecenzymes.com/role/Equipment", "longName": "010 - Disclosure - Equipment", "shortName": "Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R12": { "role": "http://geecenzymes.com/role/StockholdersEquityDeficit", "longName": "011 - Disclosure - Stockholders\u2019 Equity (Deficit)", "shortName": "Stockholders\u2019 Equity (Deficit)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R13": { "role": "http://geecenzymes.com/role/RelatedPartyTransactions", "longName": "012 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R14": { "role": "http://geecenzymes.com/role/IncomeTaxes", "longName": "013 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R15": { "role": "http://geecenzymes.com/role/CommitmentsandContingencies", "longName": "014 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R16": { "role": "http://geecenzymes.com/role/SubsequentEvents", "longName": "015 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R17": { "role": "http://geecenzymes.com/role/AccountingPoliciesByPolicy", "longName": "016 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "17", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R18": { "role": "http://geecenzymes.com/role/StockholdersEquityDeficitTables", "longName": "017 - Disclosure - Stockholders\u2019 Equity (Deficit) (Tables)", "shortName": "Stockholders\u2019 Equity (Deficit) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R19": { "role": "http://geecenzymes.com/role/RelatedPartyTransactionsTables", "longName": "018 - Disclosure - Related Party Transactions (Tables)", "shortName": "Related Party Transactions (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R20": { "role": "http://geecenzymes.com/role/SummaryofSignificantAccountingPoliciesDetails", "longName": "019 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "c40", "name": "gfoo:AverageExchangeRate", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c40", "name": "gfoo:AverageExchangeRate", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R21": { "role": "http://geecenzymes.com/role/GoingConcernDetails", "longName": "020 - Disclosure - Going Concern (Details)", "shortName": "Going Concern (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true }, "uniqueAnchor": { "contextRef": "c42", "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "unique": true } }, "R22": { "role": "http://geecenzymes.com/role/EquipmentDetails", "longName": "021 - Disclosure - Equipment (Details)", "shortName": "Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:PropertyPlantAndEquipmentNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true }, "uniqueAnchor": null }, "R23": { "role": "http://geecenzymes.com/role/StockholdersEquityDeficitDetails", "longName": "022 - Disclosure - Stockholders\u2019 Equity (Deficit) (Details)", "shortName": "Stockholders\u2019 Equity (Deficit) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "c45", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c45", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R24": { "role": "http://geecenzymes.com/role/ScheduleofFairValuetheStockOptionsBlackScholesOptionPricingModelTable", "longName": "023 - Disclosure - Stockholders\u2019 Equity (Deficit) (Details) - Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model", "shortName": "Stockholders\u2019 Equity (Deficit) (Details) - Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R25": { "role": "http://geecenzymes.com/role/ScheduleofOptionActivityTable", "longName": "024 - Disclosure - Stockholders\u2019 Equity (Deficit) (Details) - Schedule of Option Activity", "shortName": "Stockholders\u2019 Equity (Deficit) (Details) - Schedule of Option Activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R26": { "role": "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable", "longName": "025 - Disclosure - Related Party Transactions (Details) - Schedule of Related Parties Name and Relationship", "shortName": "Related Party Transactions (Details) - Schedule of Related Parties Name and Relationship", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "c54", "name": "us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c54", "name": "us-gaap:NatureOfCommonOwnershipOrManagementControlRelationships", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R27": { "role": "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable", "longName": "026 - Disclosure - Related Party Transactions (Details) - Schedule of Due to Related Parties Balances", "shortName": "Related Party Transactions (Details) - Schedule of Due to Related Parties Balances", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "c67", "name": "us-gaap:OtherLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c67", "name": "us-gaap:OtherLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R28": { "role": "http://geecenzymes.com/role/IncomeTaxesDetails", "longName": "027 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "c2", "name": "us-gaap:CapitalUnitsNetAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c2", "name": "us-gaap:CapitalUnitsNetAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } }, "R29": { "role": "http://geecenzymes.com/role/CommitmentsandContingenciesDetails", "longName": "028 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OperatingLeasePayments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OperatingLeasePayments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "f10q1223_genufood.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r14", "r407" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r10", "r19", "r243", "r246", "r271", "r311", "r312", "r424", "r425", "r426", "r429", "r430", "r431" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r48", "r407", "r472" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in- Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r213", "r214", "r215", "r331", "r429", "r430", "r431", "r466", "r473" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r31", "r32", "r195" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r73", "r94", "r112", "r141", "r153", "r157", "r162", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r238", "r240", "r253", "r299", "r354", "r407", "r417", "r437", "r438", "r469" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r91", "r96", "r112", "r162", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r238", "r240", "r253", "r407", "r437", "r438", "r469" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "gfoo_AverageExchangeRate": { "xbrltype": "perShareItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "AverageExchangeRate", "presentation": [ "http://geecenzymes.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange rate", "documentation": "Average exchange rates.", "label": "Average Exchange Rate" } } }, "auth_ref": [] }, "gfoo_AverageExchangeRates": { "xbrltype": "perShareItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "AverageExchangeRates", "presentation": [ "http://geecenzymes.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average exchange rates", "label": "Average Exchange Rates" } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r62" ] }, "us-gaap_CapitalUnitsNetAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalUnitsNetAmount", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Penalty amount", "label": "Capital Units, Net Amount", "documentation": "Net amount applicable to investors of capital units or shares." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r21", "r93", "r399" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r22" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r21", "r59", "r109" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r59" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Executive Officer [Member]", "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r433" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment and contingencies (Note 8)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r17", "r41", "r301", "r341" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://geecenzymes.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r65", "r169", "r170", "r398", "r436" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r408", "r409", "r410", "r412", "r413", "r414", "r415", "r429", "r430", "r466", "r471", "r473" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Common stock, par value", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r47" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r47", "r342" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r47" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r11", "r47", "r342", "r360", "r473", "r474" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock: $0.001 par value; 10,000,000,000 shares authorized; 808,900,041 shares issued and outstanding as of December 31, 2023 and September 30, 2023", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r47", "r302", "r407" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r20", "r98", "r100", "r106", "r295", "r308" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Concentrations of Credit Risk", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r42", "r81" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Principle of Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r33", "r402" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "gfoo_DavidTangMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "DavidTangMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable", "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "David Tang [Member]", "label": "David Tang Member" } } }, "auth_ref": [] }, "us-gaap_DeferredOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredOfferingCosts", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Offering costs", "label": "Deferred Offering Costs", "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period." } } }, "auth_ref": [ "r435" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r333", "r334", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r357", "r358", "r372", "r373", "r374", "r375", "r378", "r379", "r380", "r381", "r393", "r394", "r395", "r396", "r408", "r410" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r34", "r35", "r36", "r37", "r333", "r334", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r357", "r358", "r372", "r373", "r374", "r375", "r378", "r379", "r380", "r381", "r393", "r394", "r395", "r396", "r401", "r408", "r410" ] }, "gfoo_DiscountOnCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "DiscountOnCommonStockMember", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Discount on common stock", "label": "Discount On Common Stock Member" } } }, "auth_ref": [] }, "gfoo_DiscountsOnCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "DiscountsOnCommonStock", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "negatedLabel": "Discount on common stock", "documentation": "Discount on common stock.", "label": "Discounts On Common Stock" } } }, "auth_ref": [] }, "gfoo_DiscountsOnCommonStockPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "DiscountsOnCommonStockPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Discounts on Common Stock", "documentation": "Disclosure of accounting policy for discounts on common stock.", "label": "Discounts On Common Stock Policy Text Block" } } }, "auth_ref": [] }, "gfoo_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "DocumentAndEntityInformationAbstract", "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r421" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r422" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss per share of common stock - basic (in Dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r107", "r121", "r122", "r124", "r125", "r127", "r132", "r134", "r136", "r137", "r138", "r139", "r251", "r252", "r296", "r309", "r403" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Loss per share of common stock - diluted", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r107", "r121", "r122", "r124", "r125", "r127", "r134", "r136", "r137", "r138", "r139", "r251", "r252", "r296", "r309", "r403" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income (Loss) Per Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r24", "r25" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://geecenzymes.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax benefit, percentage", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r224" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r212" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option period", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r212" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r419" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r419" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r419" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r423" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r419" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r419" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r419" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r419" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r11", "r88", "r102", "r103", "r104", "r116", "r117", "r118", "r120", "r128", "r130", "r140", "r163", "r166", "r192", "r213", "r214", "r215", "r231", "r232", "r242", "r243", "r244", "r245", "r246", "r247", "r250", "r260", "r261", "r262", "r263", "r264", "r266", "r271", "r311", "r312", "r313", "r331", "r385" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value Measurement, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency loss", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r255", "r256", "r257", "r259", "r382" ] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation and Transactions", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r254" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r55", "r364" ] }, "gfoo_GoingConcernAbstract": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "GoingConcernAbstract", "lang": { "en-us": { "role": { "label": "Going Concern [Abstract]" } } }, "auth_ref": [] }, "gfoo_HsinTaDarrenSuMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "HsinTaDarrenSuMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable", "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Hsin-Ta (Darren) Su [Member]", "label": "Hsin Ta Darren Su Member" } } }, "auth_ref": [] }, "gfoo_HuiChuanSandraLinMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "HuiChuanSandraLinMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Hui-Chuan (Sandra) Lin [Member]", "label": "Hui Chuan Sandra Lin Member" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r53", "r75", "r141", "r152", "r156", "r158", "r297", "r306", "r404" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://geecenzymes.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r113", "r220", "r225", "r226", "r229", "r233", "r235", "r236", "r237", "r327" ] }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total amount of penalty and interest", "label": "Income Tax Examination, Penalties and Interest Accrued", "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations." } } }, "auth_ref": [ "r465" ] }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forgiveness of penalty and interest", "label": "Income Tax Examination, Penalties and Interest Expense", "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations." } } }, "auth_ref": [ "r465" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r78", "r87", "r129", "r130", "r144", "r223", "r234", "r310" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r101", "r221", "r222", "r226", "r227", "r228", "r230", "r325" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for income taxes", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r23" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "label": "Increase (Decrease) in Due to Related Parties", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r7" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Change in operating assets and liabilities", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepayment", "label": "Increase (Decrease) in Prepaid Expense", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r7" ] }, "gfoo_IncreaseDecreaseIncommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "IncreaseDecreaseIncommitmentsAndContingencies", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment and contingencies", "documentation": "Commitment and contingencies.", "label": "Increase Decrease Incommitments And Contingencies" } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Interest Income (Expense), Net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r77" ] }, "us-gaap_InterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaid", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities." } } }, "auth_ref": [ "r427" ] }, "gfoo_JiaTianJefferyLinMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "JiaTianJefferyLinMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Jia Tian (Jeffery) Lin [Member]", "label": "Jia Tian Jeffery Lin Member" } } }, "auth_ref": [] }, "gfoo_JuiPinJohnLinMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "JuiPinJohnLinMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Jui Pin (John) Lin [Member]", "label": "Jui Pin John Lin Member" } } }, "auth_ref": [] }, "gfoo_KuangMingJamesTsaiMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "KuangMingJamesTsaiMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Kuang Ming (James) Tsai [Member]", "label": "Kuang Ming James Tsai Member" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Stockholders\u2019 (Deficit) Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r52", "r74", "r304", "r407", "r428", "r434", "r467" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r16", "r92", "r112", "r162", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r239", "r240", "r241", "r253", "r407", "r437", "r469", "r470" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_NatureOfCommonOwnershipOrManagementControlRelationships": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfCommonOwnershipOrManagementControlRelationships", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Relationship with the Company", "label": "Nature of Common Ownership or Management Control Relationships", "documentation": "This element represents a description of the nature of common ownership or management control relationships with other entities, regardless of there being transactions between the entities, when the existence of that control could result in operating results or financial position of the reporting entity significantly different from that which would have been obtained if the entities' were autonomous." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r108" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flows from Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r59", "r60", "r61" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flows from Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow", "http://geecenzymes.com/role/ConsolidatedIncomeStatement", "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net Loss", "verboseLabel": "Net loss", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r54", "r61", "r76", "r90", "r97", "r99", "r104", "r112", "r119", "r121", "r122", "r124", "r125", "r129", "r130", "r135", "r141", "r152", "r156", "r158", "r162", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r252", "r253", "r307", "r362", "r383", "r384", "r404", "r416", "r437" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "No Trading Symbol Flag", "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total other (expense) income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r56" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense)", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://geecenzymes.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r432" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r141", "r152", "r156", "r158", "r404" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r268", "r269" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "General Organization and Business [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://geecenzymes.com/role/GeneralOrganizationandBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "GENERAL ORGANIZATION AND BUSINESS", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r44", "r70", "r321", "r322" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency transaction adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r6", "r9", "r71" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r4", "r258", "r265" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss)", "label": "Other Comprehensive Income (Loss), Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "verboseLabel": "Due to related parties balances", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r15", "r407" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-operating income (expenses), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r57" ] }, "us-gaap_ParticipatingPolicyPercentageOfPremiumIncome": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParticipatingPolicyPercentageOfPremiumIncome", "presentation": [ "http://geecenzymes.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes return, percentage", "label": "Participating Insurance, Percentage of Premium Income", "documentation": "Percentage of participating insurance to premium income." } } }, "auth_ref": [ "r43", "r300" ] }, "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of equipment", "label": "Payments to Acquire Other Property, Plant, and Equipment", "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [ "r58" ] }, "gfoo_PenaltyReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "PenaltyReceived", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Penalty received", "documentation": "The amount of estimated penalties accrued as of the balance sheet date arising from income tax examinations.", "label": "Penalty Received" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayment", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r95", "r167", "r168", "r400" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/GoingConcernDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private placement", "label": "Proceeds from Issuance of Private Placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://geecenzymes.com/role/Equipment" ], "lang": { "en-us": { "role": { "terseLabel": "EQUIPMENT", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r64", "r82", "r85", "r86" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/EquipmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r8", "r298", "r305", "r407" ] }, "gfoo_RateOfReturnPercentage": { "xbrltype": "percentItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "RateOfReturnPercentage", "presentation": [ "http://geecenzymes.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Return, percentage", "documentation": "Information rate of return percentage.", "label": "Rate Of Return Percentage" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable", "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r193", "r275", "r276", "r336", "r337", "r338", "r339", "r340", "r359", "r361", "r392" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "verboseLabel": "Related Party [Member]", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r114", "r115", "r275", "r276", "r277", "r278", "r336", "r337", "r338", "r339", "r340", "r359", "r361", "r392" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r275", "r276", "r468" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable", "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r365", "r366", "r369" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable", "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable", "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r193", "r275", "r276", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r336", "r337", "r338", "r339", "r340", "r359", "r361", "r392", "r468" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://geecenzymes.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "RELATED PARTY TRANSACTIONS", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r272", "r273", "r274", "r276", "r279", "r328", "r329", "r330", "r367", "r368", "r369", "r389", "r391" ] }, "gfoo_RestatedMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "RestatedMember", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Restated", "label": "Restated Member" } } }, "auth_ref": [] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAxis", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r89", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r126", "r127", "r128", "r129", "r130", "r131", "r139", "r164", "r165", "r232", "r249", "r250", "r251", "r252", "r267", "r270", "r271", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r323" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementDomain", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [ "r89", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r126", "r127", "r128", "r129", "r130", "r131", "r139", "r164", "r165", "r232", "r249", "r250", "r251", "r252", "r267", "r270", "r271", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r323" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/GoingConcernDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r49", "r67", "r303", "r315", "r320", "r326", "r343", "r407" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r88", "r116", "r117", "r118", "r120", "r128", "r130", "r163", "r166", "r213", "r214", "r215", "r231", "r232", "r242", "r244", "r245", "r247", "r250", "r311", "r313", "r331", "r473" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r105", "r112", "r142", "r143", "r151", "r154", "r155", "r159", "r160", "r161", "r162", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r253", "r297", "r437" ] }, "gfoo_ScheduleOfDueToRelatedPartiesBalancesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "ScheduleOfDueToRelatedPartiesBalancesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Due To Related Parties Balances Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable", "presentation": [ "http://geecenzymes.com/role/ScheduleofDuetoRelatedPartiesBalancesTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, off-Balance-Sheet Risks [Table]", "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition." } } }, "auth_ref": [ "r38", "r72" ] }, "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueOffBalanceSheetRisksTextBlock", "presentation": [ "http://geecenzymes.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Due to Related Parties Balances", "label": "Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined) which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition." } } }, "auth_ref": [ "r38", "r72" ] }, "gfoo_ScheduleOfFairValueTheStockOptionsBlackScholesOptionPricingModelAbstract": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "ScheduleOfFairValueTheStockOptionsBlackScholesOptionPricingModelAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model [Abstract]" } } }, "auth_ref": [] }, "gfoo_ScheduleOfOptionActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "ScheduleOfOptionActivityAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Option Activity [Abstract]" } } }, "auth_ref": [] }, "gfoo_ScheduleOfRelatedPartiesNameAndRelationshipAbstract": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "ScheduleOfRelatedPartiesNameAndRelationshipAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Related Parties Name And Relationship Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r39", "r40", "r365", "r366", "r369" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://geecenzymes.com/role/RelatedPartyTransactionsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Parties Name and Relationship", "label": "Schedule of Related Party Transactions [Table Text Block]", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r12", "r13", "r30" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value the Stock Options Black-Scholes Option Pricing Model", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r69" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r418" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://geecenzymes.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r420" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Business Segments", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r145", "r146", "r147", "r148", "r149", "r150", "r160", "r405" ] }, "gfoo_ShaoChengWillWangMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "ShaoChengWillWangMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Shao-Cheng (Will) Wang [Member]", "label": "Shao Cheng Will Wang Member" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://geecenzymes.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow", "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "verboseLabel": "Stock based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://geecenzymes.com/role/ScheduleofFairValuetheStockOptionsBlackScholesOptionPricingModelTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r209" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://geecenzymes.com/role/ScheduleofFairValuetheStockOptionsBlackScholesOptionPricingModelTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r208" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://geecenzymes.com/role/ScheduleofFairValuetheStockOptionsBlackScholesOptionPricingModelTable" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r210" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options to purchase share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Underlying Shares, Forfeited or expired", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r445" ] }, "gfoo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedToPurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedToPurchaseShares", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted options", "documentation": "Share based compensation arrangement by share based payment award options granted to purchase shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted To Purchase Shares" } } }, "auth_ref": [] }, "gfoo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedToPurchaseSharesPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedToPurchaseSharesPricePerShare", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options per share", "documentation": "Share based compensation arrangement by share based payment award options granted to purchase share price share.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted To Purchase Shares Price Per Share" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Underlying Shares, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r199" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r202" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Beginning Outstanding", "periodEndLabel": "Aggregate Intrinsic Value, Ending Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Underlying Shares, Beginning Outstanding", "periodEndLabel": "Number of Underlying Shares, Ending Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r197", "r198" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, Beginning Outstanding", "periodEndLabel": "Weighted average exercise price, Ending Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r197", "r198" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value Vested and expected to vest", "verboseLabel": "Aggregate Intrinsic Value, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r204" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Underlying Shares, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r204" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r204" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Underlying Shares Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r203" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r203" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Exercised", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r200" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Forfeited or expired", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r201" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Granted", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r199" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche One [Member]", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r194", "r196", "r205", "r206", "r207", "r208", "r211", "r216", "r217", "r218", "r219" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion per share", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting right percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r439" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r406" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://geecenzymes.com/role/ScheduleofFairValuetheStockOptionsBlackScholesOptionPricingModelTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r207" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual Life (years), Beginning Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r68" ] }, "gfoo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual Life (years), Ending Outstanding", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Terms" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual Life (years), Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r204" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual Life (years) Vested and expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r203" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance (in Shares)", "periodEndLabel": "Balance (in Shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://geecenzymes.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r62", "r110" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r11", "r18", "r88", "r102", "r103", "r104", "r116", "r117", "r118", "r120", "r128", "r130", "r140", "r163", "r166", "r192", "r213", "r214", "r215", "r231", "r232", "r242", "r243", "r244", "r245", "r246", "r247", "r250", "r260", "r261", "r262", "r263", "r264", "r266", "r271", "r311", "r312", "r313", "r331", "r385" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r116", "r117", "r118", "r140", "r282", "r324", "r332", "r335", "r336", "r337", "r338", "r339", "r340", "r342", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r357", "r358", "r359", "r361", "r363", "r364", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r385", "r411" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r116", "r117", "r118", "r140", "r282", "r324", "r332", "r335", "r336", "r337", "r338", "r339", "r340", "r342", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r356", "r357", "r358", "r359", "r361", "r363", "r364", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r385", "r411" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://geecenzymes.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Underlying Shares, Exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r11", "r46", "r47", "r67", "r200" ] }, "gfoo_StockIssuedDuringValueIssuanceOfCommonStockForDebtConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "StockIssuedDuringValueIssuanceOfCommonStockForDebtConversion", "crdr": "credit", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "documentation": "The amount of stock issued during value issuance of common stock for debt conversion.", "label": "Stock Issued During Value Issuance Of Common Stock For Debt Conversion" } } }, "auth_ref": [] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionMember", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Options [Member]", "label": "Equity Option [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r410" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://geecenzymes.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet", "http://geecenzymes.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders\u2019 (Deficit) Equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r47", "r50", "r51", "r63", "r344", "r360", "r386", "r387", "r407", "r417", "r428", "r434", "r467", "r473" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 (Deficit) Equity", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "gfoo_StockholdersEquityDeficitDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "StockholdersEquityDeficitDetailsTable", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficit) (Details) [Table]" } } }, "auth_ref": [] }, "gfoo_StockholdersEquityDeficitLineItems": { "xbrltype": "stringItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "StockholdersEquityDeficitLineItems", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Deficit) [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "terseLabel": "STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r66", "r111", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r248", "r388", "r390", "r397" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://geecenzymes.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r280", "r281" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://geecenzymes.com/role/GoingConcern" ], "lang": { "en-us": { "role": { "terseLabel": "GOING CONCERN", "label": "Substantial Doubt about Going Concern [Text Block]", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r45" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://geecenzymes.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense", "crdr": "debit", "presentation": [ "http://geecenzymes.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Penalty imposed", "label": "Unrecognized Tax Benefits, Income Tax Penalties Expense", "documentation": "Amount of expense for penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r465" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://geecenzymes.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r26", "r27", "r28", "r79", "r80", "r83", "r84" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464" ] }, "gfoo_VestingMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "VestingMember", "presentation": [ "http://geecenzymes.com/role/StockholdersEquityDeficitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Member]", "label": "Vesting Member" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares outstanding - diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r133", "r138" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://geecenzymes.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares outstanding - basic (in Shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r132", "r138" ] }, "gfoo_WenPiaoJackLaiMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "WenPiaoJackLaiMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Wen-Piao (Jack) Lai [Member]", "label": "Wen Piao Jack Lai Member" } } }, "auth_ref": [] }, "gfoo_YiLungOliverLinMember": { "xbrltype": "domainItemType", "nsuri": "http://geecenzymes.com/20231231", "localname": "YiLungOliverLinMember", "presentation": [ "http://geecenzymes.com/role/ScheduleofRelatedPartiesNameandRelationshipTable" ], "lang": { "en-us": { "role": { "terseLabel": "Yi Lung (Oliver) Lin [Member]", "label": "Yi Lung Oliver Lin Member" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "50", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479756/944-50-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(14)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r410": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r416": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r418": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r419": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r422": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480341/340-10-S99-1" }, "r436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 49 0001213900-24-015210-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-015210-xbrl.zip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end XML 50 f10q1223_genufood_htm.xml IDEA: XBRL DOCUMENT 0001510518 2023-10-01 2023-12-31 0001510518 2024-02-15 0001510518 2023-12-31 0001510518 2023-09-30 0001510518 us-gaap:RelatedPartyMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember 2023-09-30 0001510518 2022-10-01 2022-12-31 0001510518 us-gaap:CommonStockMember 2023-09-30 0001510518 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001510518 gfoo:DiscountOnCommonStockMember 2023-09-30 0001510518 us-gaap:RetainedEarningsMember 2023-09-30 0001510518 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001510518 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001510518 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001510518 gfoo:DiscountOnCommonStockMember 2023-10-01 2023-12-31 0001510518 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001510518 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0001510518 us-gaap:CommonStockMember 2023-12-31 0001510518 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001510518 gfoo:DiscountOnCommonStockMember 2023-12-31 0001510518 us-gaap:RetainedEarningsMember 2023-12-31 0001510518 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001510518 gfoo:RestatedMember us-gaap:CommonStockMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001510518 gfoo:RestatedMember gfoo:DiscountOnCommonStockMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:RetainedEarningsMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001510518 gfoo:RestatedMember 2022-09-30 0001510518 gfoo:RestatedMember us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember gfoo:DiscountOnCommonStockMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember 2022-10-01 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:CommonStockMember 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001510518 gfoo:RestatedMember gfoo:DiscountOnCommonStockMember 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:RetainedEarningsMember 2022-12-31 0001510518 gfoo:RestatedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001510518 gfoo:RestatedMember 2022-12-31 0001510518 2022-09-30 0001510518 2022-12-31 0001510518 2022-10-01 2023-09-30 0001510518 2023-02-24 0001510518 2023-02-24 2023-02-24 0001510518 2023-03-24 0001510518 2023-03-24 2023-03-24 0001510518 srt:ChiefExecutiveOfficerMember 2022-07-15 2022-07-15 0001510518 srt:ChiefExecutiveOfficerMember 2022-07-15 0001510518 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-12-31 0001510518 us-gaap:StockOptionMember gfoo:VestingMember 2023-10-01 2023-12-31 0001510518 gfoo:VestingMember 2023-10-01 2023-12-31 0001510518 us-gaap:StockOptionMember 2023-10-01 2023-12-31 0001510518 us-gaap:StockOptionMember 2021-10-01 2022-09-30 0001510518 gfoo:YiLungOliverLinMember 2023-10-01 2023-12-31 0001510518 gfoo:JuiPinJohnLinMember 2023-10-01 2023-12-31 0001510518 gfoo:JiaTianJefferyLinMember 2023-10-01 2023-12-31 0001510518 gfoo:WenPiaoJackLaiMember 2023-10-01 2023-12-31 0001510518 gfoo:ShaoChengWillWangMember 2023-10-01 2023-12-31 0001510518 gfoo:KuangMingJamesTsaiMember 2023-10-01 2023-12-31 0001510518 gfoo:HsinTaDarrenSuMember 2023-10-01 2023-12-31 0001510518 gfoo:HuiChuanSandraLinMember 2023-10-01 2023-12-31 0001510518 gfoo:DavidTangMember 2023-10-01 2023-12-31 0001510518 us-gaap:RelatedPartyMember gfoo:HsinTaDarrenSuMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember gfoo:HsinTaDarrenSuMember 2023-09-30 0001510518 us-gaap:RelatedPartyMember gfoo:DavidTangMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember gfoo:DavidTangMember 2023-09-30 0001510518 us-gaap:RelatedPartyMember 2023-12-31 0001510518 us-gaap:RelatedPartyMember 2023-09-30 0001510518 2021-09-30 0001510518 2019-10-01 2020-09-30 0001510518 2020-10-01 2021-09-30 shares iso4217:USD iso4217:USD shares pure 10-Q true 2023-12-31 000-56112 GENUFOOD ENERGY ENZYMES CORP. NV 1108 S. Baldwin Avenue Suite 107 Arcadia CA 91007 (855) 707-2077 N/A Non-accelerated Filer true false false 808900041 19617 125924 8000 8187 27617 134111 96142 67451 123759 201562 111849 100849 37 37 4437 14730 116323 115616 32976 32226 0.001 0.001 10000000000 10000000000 808900041 808900041 808900041 808900041 808900 808900 17008342 16989592 7241581 7241581 -10601201 -10503191 -25540 53720 123759 201562 95616 148995 95616 148995 -95616 -148995 -44 -43 -750 -750 -794 -793 -96410 -149788 1600 -98010 -149788 -85 -98010 -149873 808900041 299686921 808900041 808900 16989592 -7241581 -10503191 53720 18750 18750 -98010 -98010 808900041 808900 17008342 -7241581 -10601201 -25540 299686921 299687 16927592 -7241581 -9875489 -193558 -83349 18750 18750 -85 -85 -149788 -149788 299686921 299687 16946342 -7241581 -10025277 -193643 -214472 -98010 -149788 18750 18750 -187 -7836 11000 17401 -10293 30182 750 750 -77616 -74869 28691 15005 -28691 -15005 -106307 -89874 125924 136400 19617 46526 1600 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 1 – GENERAL ORGANIZATION AND BUSINESS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Genufood Energy Enzymes Corp., USA (the “Company” or “GEEC”) was incorporated under the laws of the State of Nevada on June 21, 2010. On February 13, 2012, GEEC incorporated a wholly-owned subsidiary, Genufood Enzymes (S) Pte Ltd (“GESPL”) in Singapore, which was dissolved on January 9, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Since its inception, the Company has always been in the development stage and never generated significant revenues. The Company is currently developing business in Electric Vehicle Charge station. The Company has engaged in business agreements and development with various parties. The Company has initiated its electric vehicle charging station business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On August 1, 2022, the board of directors (the “Board”) of the Company unanimously approved to expand our business in the area of electric vehicle supply equipment (“EVSE”) and will direct the management team to implement its new business plan in such industry. On August 16, 2022, the Company formally announced its intention to reposition as EVSE solutions provider, seeking to grow business in EVSE industry, including building, owning, and operating the next generation of electric vehicle charging stations in the U.S. The Company intends to bring convenient, reliable, and accessible charging experience to electric vehicle drivers, utilizing frictionless technology and carbon-neutral vehicle-charging infrastructure.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On October 26, 2022, the Company entered into three Charging Station Site Host Agreements (the “Agreements”) with two institutions (the “Site Hosts”), respectively, pursuant to which the Site Hosts agree to allow the Company to install its electric vehicle charging stations at the locations set forth in the Agreements (the “Charging Stations”). Under the Agreements, the Company has agreed to share the revenue generated by the sales of electricity at the Charging Stations with the Site Hosts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As of December 31, 2023, the Company has two sites under construction for charging stations and three sites under planning.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Basis of Presentation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company’s condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending September 30, 2024. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Principle of Consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The condensed consolidated financial statements include the accounts of GEEC and its wholly-owned subsidiary GESPL. All significant inter-company accounts and transactions have been eliminated in consolidation. The wholly-owned subsidiary of the Company did not have business activities prior to its dissolution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Concentrations of Credit Risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, to the extent balances exceeded limits that were insured by the Federal Deposit Insurance Corporation. The Company does not require collateral and maintains reserves for potential credit losses. Such losses have historically been immaterial and have been within management’s expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Cash and Cash Equivalents</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company considers all highly liquid instruments with original maturities of three months or less when acquired to be cash equivalents. As of December 31, 2023 and September 30, 2023, the Company did not have cash equivalents. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Fair Value of Financial Instruments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs are quoted prices available for identical assets and liabilities in active markets.</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets or other inputs that are observable or can be corroborated by observable market data.</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs are less observable and reflect our own assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company’s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued expenses and due to related parties. The carrying amounts of such financial instruments in the accompanying consolidated balance sheets approximate their fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Foreign Currency Translation and Transactions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The reporting and functional currency of GEEC is the USD. The functional currency of GESPL, a wholly owned subsidiary of GEEC, is the Singapore Dollar (“SGD”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For financial reporting purposes, the financial statements of the Company’s Singapore subsidiary, which are prepared using the SGD, are translated into the Company’s reporting currency, USD. Assets and liabilities are translated using the exchange rate on the balance sheet date, which was 0.6970 as of September 30, 2022. Revenue and expenses are translated using average exchange rates prevailing during each reporting period. The 0.7214 average exchange rates were used to translate revenues and expenses for the three months ended December 31, 2022. Stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive loss in stockholders’ deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. The resulting exchange difference, presented as foreign currency transaction loss, is included in the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Business Segments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company operates in only one segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Net Income (Loss) Per Share</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. There were no potential dilutive debt or equity instruments issued and outstanding at any time during the three months ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Discounts on Common Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Common stock issued lower than the Company’s par value is treated as common stock issued under discounts. The portion of the discount is shown separately as a deduction from the Company’s account of common stock on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Stock-Based Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company accounts for its stock-based compensation in which the Company obtains employee services in share-based payment transactions under FASB ASC Topic 718, Compensation – Stock Compensation, which requires the Company to expense the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Income Taxes</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company considers positive and negative evidence when determining whether a portion or all of its deferred tax assets will more likely than not be realized. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, its experience with tax attributes expiring unused, and its tax planning strategies. The ultimate realization of deferred tax assets is dependent upon its ability to generate sufficient future taxable income within the carry-forward periods provided for in the tax law and during the periods in which the temporary differences become deductible. When assessing the realization of deferred tax assets, the Company has considered possible sources of taxable income including (i) future reversals of existing taxable temporary differences, (ii) future taxable income exclusive of reversing temporary differences and carry-forwards, (iii) future taxable income arising from implementing tax planning strategies, and (iv) specific known trend of profits expected to be reflected within the industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company recognizes a tax benefit associated with an uncertain tax position when, in its judgment, it is more likely than not that the position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The Company’s liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. The Company’s effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company classifies interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There were no current and deferred income tax provision recorded for the three months ended December 31, 2023 and 2022 since the Company has recurring losses.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Recent Accounting Pronouncements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs” or “ASU”) on the Company’s consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s consolidated financial position or results of operations. Recently issued ASUs that the Company feels may be applicable to the Company are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In August 2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU addresses complex financial instruments that have characteristics of both debt and equity. The application of this ASU would reduce the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models would result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. To date, no such bifurcation has been necessary. Management is evaluating the potential impact. This ASU becomes effective for fiscal years beginning after December 15, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Basis of Presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company’s condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring items, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily indicative of the results to be expected for the full year ending September 30, 2024. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Principle of Consolidation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The condensed consolidated financial statements include the accounts of GEEC and its wholly-owned subsidiary GESPL. All significant inter-company accounts and transactions have been eliminated in consolidation. The wholly-owned subsidiary of the Company did not have business activities prior to its dissolution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Concentrations of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Financial instruments that potentially subject the Company to significant concentrations of credit risk consisted primarily of cash, to the extent balances exceeded limits that were insured by the Federal Deposit Insurance Corporation. The Company does not require collateral and maintains reserves for potential credit losses. Such losses have historically been immaterial and have been within management’s expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Cash and Cash Equivalents</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company considers all highly liquid instruments with original maturities of three months or less when acquired to be cash equivalents. As of December 31, 2023 and September 30, 2023, the Company did not have cash equivalents. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Fair Value of Financial Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 inputs are quoted prices available for identical assets and liabilities in active markets.</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 inputs are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets or other inputs that are observable or can be corroborated by observable market data.</span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 inputs are less observable and reflect our own assumptions.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company’s financial instruments consist principally of cash and cash equivalents, accounts payable and accrued expenses and due to related parties. The carrying amounts of such financial instruments in the accompanying consolidated balance sheets approximate their fair values due to their relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks arising from these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Foreign Currency Translation and Transactions</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The reporting and functional currency of GEEC is the USD. The functional currency of GESPL, a wholly owned subsidiary of GEEC, is the Singapore Dollar (“SGD”).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">For financial reporting purposes, the financial statements of the Company’s Singapore subsidiary, which are prepared using the SGD, are translated into the Company’s reporting currency, USD. Assets and liabilities are translated using the exchange rate on the balance sheet date, which was 0.6970 as of September 30, 2022. Revenue and expenses are translated using average exchange rates prevailing during each reporting period. The 0.7214 average exchange rates were used to translate revenues and expenses for the three months ended December 31, 2022. Stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive loss in stockholders’ deficit.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. The resulting exchange difference, presented as foreign currency transaction loss, is included in the accompanying consolidated statements of operations.</span></p> 0.697 0.7214 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Business Segments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company operates in only one segment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Net Income (Loss) Per Share</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share.” Basic loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive. There were no potential dilutive debt or equity instruments issued and outstanding at any time during the three months ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Discounts on Common Stock</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Common stock issued lower than the Company’s par value is treated as common stock issued under discounts. The portion of the discount is shown separately as a deduction from the Company’s account of common stock on the Company’s consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Stock-Based Compensation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company accounts for its stock-based compensation in which the Company obtains employee services in share-based payment transactions under FASB ASC Topic 718, Compensation – Stock Compensation, which requires the Company to expense the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Income Taxes</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company considers positive and negative evidence when determining whether a portion or all of its deferred tax assets will more likely than not be realized. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, its experience with tax attributes expiring unused, and its tax planning strategies. The ultimate realization of deferred tax assets is dependent upon its ability to generate sufficient future taxable income within the carry-forward periods provided for in the tax law and during the periods in which the temporary differences become deductible. When assessing the realization of deferred tax assets, the Company has considered possible sources of taxable income including (i) future reversals of existing taxable temporary differences, (ii) future taxable income exclusive of reversing temporary differences and carry-forwards, (iii) future taxable income arising from implementing tax planning strategies, and (iv) specific known trend of profits expected to be reflected within the industry.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company recognizes a tax benefit associated with an uncertain tax position when, in its judgment, it is more likely than not that the position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The Company’s liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. The Company’s effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company classifies interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">There were no current and deferred income tax provision recorded for the three months ended December 31, 2023 and 2022 since the Company has recurring losses.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.50 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>Recent Accounting Pronouncements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs” or “ASU”) on the Company’s consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s consolidated financial position or results of operations. Recently issued ASUs that the Company feels may be applicable to the Company are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">In August 2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU addresses complex financial instruments that have characteristics of both debt and equity. The application of this ASU would reduce the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models would result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. To date, no such bifurcation has been necessary. Management is evaluating the potential impact. This ASU becomes effective for fiscal years beginning after December 15, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 3 – GOING CONCERN</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As of December 31, 2023 and September 30, 2023, the Company had an accumulated deficit of $10,601,201 and $10,503,191, respectively. To date, the Company’s cash flow requirements have been primarily met through proceeds received from sales of its common stock. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company received $362,000 from private placement during the year ended September 30, 2023. The proceeds have been used for operation expenses. Management is currently seeking additional funds for future operation.</span></p> -10601201 -10503191 362000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 4 – EQUIPMENT</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As of December 31, 2023 and September 30, 2023 the Company had equipment of $96,142 and $67,451, respectively, consisting of equipment to be installed at its electric vehicle charging stations and related installation costs.</span></p> 96142 67451 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company is authorized under its articles of incorporation, as amended, to issue 10,000,000,000 shares of Common Stock, par value $0.001 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On February 24, 2023, the Company conducted a private placement offering and sold 375,000,000 shares of common stock at $0.001 per share, for gross proceeds of $375,000, and incurred offering costs of $13,000.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On March 24, 2023, the Company issued 134,213,120 shares of common stock to its board of directors, officers, and former officers to repay the compensation due to them in the aggregate amount of $134,213 at the conversion rate of $0.001 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Stock Options</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On July 15, 2022, the CEO, David Tang, was granted 15,000,000 options to purchase shares at $0.01 per share. As of December 31, 2023, total options granted was 15,000,000 and 5,312,500 was vested. This option will be subject to a vesting schedule providing for twenty-five percent (25%) vesting after the first twelve (12) months of employment and monthly vesting as to the remaining seventy-five percent (75%) of the shares over the following thirty-six (36) months after the first anniversary of the employment commencement date. These stock options are exercisable over a maximum period of 10 years from the grant date. The weighted average grant date fair value of options granted during the year ended September 30, 2022 was $0.02.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair value of these options, over the requisite service period, or vesting period. Accordingly, the Company recognized stock-based compensation expense of $18,750 and $18,750, respectively, which was included in the general and administrative expenses in the consolidated statements of operations for the three months ended December 31, 2023 and 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The fair value of the stock options listed above was determined using the Black-Scholes option pricing model with the following assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify">Risk-free interest rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2.99</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.08 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">379.35</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The following is a summary of the option activity for the three months ended December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Options</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Underlying<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> Life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> Intrinsic<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at October 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">15,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">–</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">–</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">–</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">–</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">15,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">8.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">–</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Vested and expected to vest as of December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">15,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">8.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">–</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Exercisable at December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5,312,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">8.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">–</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">As of December 31, 2023<i>,</i> unrecognized total compensation cost associated with these options was $190,428. This expense is expected to be recognized over a weighted-average period of 2.54 years.</span></p> 10000000000 0.001 375000000 0.001 375000 13000 134213120 134213 0.001 15000000 0.01 15000000 5312500 0.25 0.75 P10Y 0.02 18750 18750 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The fair value of the stock options listed above was determined using the Black-Scholes option pricing model with the following assumptions:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify">Risk-free interest rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2.99</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Expected term</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.08 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">379.35</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table> 0.0299 P6Y29D 3.7935 0 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The following is a summary of the option activity for the three months ended December 31, 2023:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Options</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Underlying<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> Life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<br/> Intrinsic<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at October 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">15,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">–</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">–</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">–</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">–</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">–</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">–</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">15,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">8.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">–</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Vested and expected to vest as of December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">15,000,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">8.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">–</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Exercisable at December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5,312,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right">0.01</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">8.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">–</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 15000000 0.01 15000000 0.01 P8Y6M 15000000 0.01 P8Y6M 5312500 0.01 P8Y6M 190428 P2Y6M14D <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 6 – RELATED PARTY TRANSACTIONS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Related Parties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 25%; border-bottom: black 1.5pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of related parties</b></span></td> <td style="width: 2%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 73%; border-bottom: black 1.5pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship with the Company</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yi Lung (Oliver) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal shareholder</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jui Pin (John) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal shareholder, Chairman of the Board, President, and Director</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jia Tian (Jeffery) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former Chief Executive Officer</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen-Piao (Jack) Lai</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shao-Cheng (Will) Wang</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former Chief Financial Officer</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuang Ming (James) Tsai</span></td> <td style="vertical-align: bottom; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Chief Financial Officer</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hsin-Ta (Darren) Su</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, Treasurer</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hui-Chuan (Sandra) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Secretary, daughter of Jui Pin (John) Lin</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Tang</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Due to Related Parties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company’s due to related parties balances are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; text-indent: -0.25in; padding-left: 0.25in">Hsin-Ta (Darren) Su</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,496</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">707</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">David Tang</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,941</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,023</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.25in; padding-left: 0.25in">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The related party balances are unsecured, interest-free and due on demand.</span></p> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b><i>Related Parties</i></b></span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 25%; border-bottom: black 1.5pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of related parties</b></span></td> <td style="width: 2%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 73%; border-bottom: black 1.5pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Relationship with the Company</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yi Lung (Oliver) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal shareholder</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jui Pin (John) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal shareholder, Chairman of the Board, President, and Director</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jia Tian (Jeffery) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former Chief Executive Officer</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wen-Piao (Jack) Lai</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shao-Cheng (Will) Wang</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former Chief Financial Officer</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kuang Ming (James) Tsai</span></td> <td style="vertical-align: bottom; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Chief Financial Officer</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hsin-Ta (Darren) Su</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, Treasurer</span></td></tr> <tr> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hui-Chuan (Sandra) Lin</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Secretary, daughter of Jui Pin (John) Lin</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Tang</span></td> <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="vertical-align: top; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr> </table> Principal shareholder Principal shareholder, Chairman of the Board, President, and Director Former Chief Executive Officer Director Former Chief Financial Officer Director and Chief Financial Officer Director, Treasurer Director and Secretary, daughter of Jui Pin (John) Lin Chief Executive Officer <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company’s due to related parties balances are as follows:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; text-indent: -0.25in; padding-left: 0.25in">Hsin-Ta (Darren) Su</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,496</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">707</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">David Tang</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,941</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,023</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt; text-indent: -0.25in; padding-left: 0.25in">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,437</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1496 707 2941 14023 4437 14730 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 7 – INCOME TAXES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company has not generated any revenue from any source in the United States and had consolidated net loss for all the years since inception in 2010. Management believes GEEC does not have any U.S. income tax liability due. However, even though the Company does not have U.S. income tax liability, it may be required to file Form 5471 each year with the Internal Revenue Service (the “IRS”) of Department of Treasury. GEEC falls in the Category Five Filer (as a domestic corporation). The Company used to have subsidiaries: GEECIS in Sri Lanka that was established in May 2011, GESPL in Singapore that was established in February 2012, and GESTL in Thailand that was established in December 2014. The subsidiaries in Sri Lanka and Thailand were disposed in 2014 and 2016, respectively. The Singapore subsidiary has been inactive since 2016 and dissolved in January 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Internal Revenue Code (“IRC”) Section 6038(a) requires information reporting with respect to certain foreign corporations (Form 5471) and describes the information required to be reported on this form. IRC Section 6038(b)(1) provides for a monetary penalty of $10,000 for each Form 5471 that is filed after the due date of the income tax return (including extensions) or does not include the complete and accurate information described in Section 6038(a). According to IRS rules, a penalty may apply to each Form 5471 which is filed after the due date of the income tax return. The penalty will be applied whether or not any tax is due on Form 1120.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company believes that based on the current information available, it is difficult to determine whether it is probable that the Company will be charged penalties by IRS for the late filing of Form 5471 and even if it will be, it is difficult to reasonably estimate the amount of penalties that may be assessed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">During the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30, 2020. The Company has engaged an outside professional advisor to seek for forgiveness of the penalty and interest thereon in the amount of $7,976, for a total of $32,976, which was still pending as of December 31, 2023.</span></p> 10000 25000 0.25 7976 32976 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 8 – COMMITMENTS AND CONTINGENCIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company terminated its previous virtual office agreement in Los Angeles, California and has established a new virtual office in Arcadia, California. The new arrangement is on a month-to-month basis at a cost of $200 per month. As of December 31, 2023, the Company has no material commitments under operating leases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">During the fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30, 2020 (see Note 7).</span></p> 200 25000 0.25 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><b>NOTE 9 – SUBSEQUENT EVENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date when the consolidated financial statements were issued and determined that no subsequent events occurred that would require adjustment to or disclosure in the consolidated financial statements.</span></p> NONE Yes Yes 299686921 808900041 false --09-30 Q1 2024 false 0001510518 00-0000000 true Less than $0.01 per share